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CHAPTER Is 
; 
AN INTRODUCTION TO ~HE DISEASES OF . 
PORPHYRIN METABOLISM. 
"Nature is nowhere accustomed more openly to display 
her secret mysteries than in cases where she shows 
traces of her workings apart from the beaten path ••• 
for it has been found in almost all things, that 
what they contain of useful and applicable is hardly 
perceived unless we are deprived of them or they 
become deranged in ~ome way." Harvey 1 (1847) 
The syndromes of disordered porphyrin metabolism have puzzled 
physicians and investigators alike since their first description in 
1874 (1)(2). Although they are rare in most parts of the world, 
their catholic manifestations mimic diseases in all fields of medicine, 
but the presence of porphyrins in biological fluids is often rapidly 
detectable by their dramatic red fluorescence in ultra-violet light. 
However, although great advances have been made in porphyrin bio-
chemistry, there are aspects of the biosynthetic pathway which remain 
to be elucidated. 
HISTORICAL REVIEW. 
First references to .porphyrins were made in the 1840's by 
Scherer (3) and Mulder (4) who treated blood with concentrated sul-
phuric acid and revealed a purple-red iron-free fluid. This was named 
cruentine by Thudichum in a report to the Privy Council in Great Britain 
in 1867 (5). He demonstrated its fluorescence in a cone of sunlight 
collected by a system of quartz lenses, and could define its spectrum. 





he named the major part haematoporphyrin. In 1874 (1)t2) the first 
case was described with symptoms and signs characteristic of congeni-
tal porphyria, although at the time it was entitled Pemphigus Leprosus. 
Investigation of the urine from this patient revealed two pigments 
· designated urorubrohaematin and urofuschsohaematin. The former was 
later renamed urohaemotoporphyrin because of its resemblance to 
haemotoporphyrin. In 1911, GUnther(7) collected all reports of syn-
dromes and made the first classification of the disease. Garrod(8) 
included congenital porphyria as an inborn error of metabolism and 
credited GUnther with its first recognition. In 1937, Waldenstrom(9) 
reviewed many of GUnther's cases, and 103 patients with porphyria 
found in Sweden. He also reported on the chemical aspects of the 
disease which had been the especial concern of Fischer and Rimington. 
The name Porphyrias was proposed for the diseases, rather than 
Haematoporphyrias (as per Gunther), because the naturally-occurring 
I 
porphyrins had been found to differ structurally from the chemical 
artefact, haematoporphyrin. The porphyrins found in the urine and 
faeces were named uro- and coproporphyrin respectively, while that 
found as the naturally-occurring porphyrin of haem was known as proto-
porphyrin. Waldenstrom also noted the excretion of porphobilinogen 
by apparently healthy relatives of patients with acute porphyria and 




A CLASSIFICATION OF PORPHYRIA. 
- ERYTHROPOEITIC 
1: congenital erythropoeitic porphyria 
2: eryt hropoeitic protoporphyria 
- HEPATIC 
Inherited 
1: swedish -acute i"ntetmittent 
2: s .a. genetic - variegate 
3: ? idiopathic coproporphyria 
Acquired 
1: porphyria cutanea tarda 
2: secondary to fungicide (HCB) 
3: secondary to hepatoma (1 case) 
4: secondary to other disease 
- EXPERIMENTAL 
1: in vivo 















































































































































































































































































































































































Since that time, a number of classifications have been proposed 
but it is probable that a wholly satisfactory solution will only be 
achieved when all the enzymatic defects of the porphyrias have been 
elucidated. 
CLASSIFICATION 
A classification which is acceptable in the light of present 
knowledge may be compounded from those suggested by Watson(lO) and 
Eales(ll), and is shown in fig. I. A summary of the clinical and 
biochemical manifestations of some of these symptoms is presented in 
fig. II, and further description follows below. 
A: ERYTHROPOEITIC 
(i) Congenital Erythropoeitic porphyria - is a rare disease 
which is inherited as an autosomal recessive. The initial manifes-
tation is of the excretion of red urine, often occurring in a young 
child. As exposure to sunlight increases, photo-sensitivity is 
revealed with the occurrence of a vesicular or bullous eruption 
hydroa aestivale, which in many cases proceeds to marked scarring and 
contracture(7) formation. Hypertrichosis(7)(12) and erythro-
dontia(7)(13) are other features. Splenomegaly is an almost constant 
accompaniment but the hypertension and neurological symptoms of other 
forms of porphyria are not found. Increased haemolytic activity is 
indicated by the finding of normochromic anaemia, with an increase 
in circulating normoblasts and reticulocytes, some of .which fluoresce. 
' 
4. 
Faecal urobilinogen(14) is increased. This haemolytic component may 
only occur in certain phases of the disease. Urinary excretion of 
uroporphyrin is markedly increased(7)(15)(16) as to a lesser extent 
is coproporphyrin(7)(15)(16)(17)(18). Small amounts of porphyrins 
~ 
with seven, six, five and three carboxyl groups have been demon-
strated(15)(16). The uro- and coproporphyrin occur predominantly in 
type I isomer form(19)(20) but type III isomers have been recovered 
(17)(18)(21). The excretion of porphyrin precursors is normal. Faecal 
coproporphyrin is increased, and uroporphyrin slightly, while proto-
porphyrin appears normal(l6). Red cell porphyrins are increase~(15) 
(16)(17)(22)(23). Because the primary defect appears to be the over-
production of isomer I, the most likely metabolic fault is in the 
mechanism converting porphobilinogen (PBG) to uroporphyrinogen (UROgen) 
(24)(25)(26). As will be detailed in chapter II, this involves the 
enzymes PBG deaminase or UROgen deaminase. 
(ii) Erythropoeitic protoporphyria has only recently been 
described(27)(28). It does not exhibit any of the characteristics of 
congenital erythropoeitic porphyria, but photosensitivity manifests 
as solar urticaria(27)(29) with pruritus, erythema(27)(30) and oedema 
and little tendency to bullous formation. The spectrum of ultra 
violet light causing this has been shown to be precisely related to 
that of maximal absorption of porphyrins(27) (the Soret band). 
Scarring does not follow these cutaneous manifestations. In the 
5. 
majority of patients the morphology of blood and bone marrow components 
is norma1(27). The urinary excretion of porphyrin precursors and por-
phyrins(27)(29)(30) is normal, but protoporphyrin is markedly increased 
in circulating erythrocytes and in faeces(27). Occasionally, faecal 
coproporphyrin is increased. There is no increase of uroporphyrin in 
the faeces or tissues. The nature of the defect is suggested to be 
diminished activity of the ferrochelatase (haem synthetase), but iron 
utilisation(27) and haem synthesis by the bone marrow proceeds normally 
(31). The impression of various workers is that the defect is not 




(i) Acute Intermittent Porphyria - has as its most prominent 
symptom abdominal pain of a colicky nature with minimal signs. The 
association with constipation and vomiting leads to misdiagnosis as a 
surgical abdominal emergency(33)(34). The manifestations are charac-
teristically intermittent(35)(36)(37). Associated neurological mani-
festations may involve any aspect of neural function and are extremely 
variable. Tachycardia and hypertension occur frequently. The hypona-
trae~ia accompanying acute attacks has been related to inappropriate 
secretion of anti-diuretic hormone(38)(39) but proof of this is lacking 
6. 
in a situation where fluid balance is markedly disturbed. Acute 
attacks are often precipitated by exposure to drugs, especially the 
barbiturate and sulphonamide groups, griseofulvin or oestrogens(9)(36) 
(37)(40)(41)(42)(43)(44)(45). Chemically the characteristic finding 
is of markedly increased uri~ary PBG(9)(46)(47) and 6 -amino-
laevulinic-acid (ALA)(48)(49)50)(51)(52). Increased levels of por-
phyrins may occur only after the urine has been standing a while(53) 
and most occur as metal complexes, often with zinc(36)(54) although 
total zinc excretion ls not increased(55). The concentration• of 
urinary amino acids(56) and indolic compounds(57) has been found to 
be increased. A slight to moderate increase in faecal porphyrin of 
all three types may occur. Only the liver has been shown to contain 
large amounts of PBG. Increased formation of ALA or a block in non-
porphyrin metabolism after the formation of ALA are possible explana-
tions for the emphasis on the excretion of porphyrin precursors(9)(22) 
I 
(35)(36)(37). Both the phenomena of end-product inhibition(58)(59)(60) 
or defective genetic regulation of ALA-synthetase could account for 
part of the biochemical disorder, and this is suggested by the demon-
stration of elevated levels of ALA-synthetase in the livers of these 
patients(61)(62). Manifestation of this porphyria before puberty is 
rare(37) suggesting a relationship with ~ormonal activity. However, 
the administration of oestrogens to normal individuals has no effect 
on porphyrin metabolism(63). The condition is inherited as an auto-
somal dominant character. 
7. 
(ii) S.A. Genetic Porphyria - also known as hereditary proto-
porphyria, is characterised by a family history of skin sensitivity to 
light and trauma known colloquially in South Africa as "sagte vel". 
Acute attacks occur occasionally with abdominal and neurological mani-
festations and are frequently precipitated by drugs(63)(64)(65) especi-
ally the barbiturates. Neuropathic involvement is often severe and 
persists after subsidence of the acute episode. During an acute 
attack, ALA and PBG are increased in the urine, with marked elevation 
of uro and coproporphyrin in the urine and coproporphyrin and proto-
porphyrin in the faeces. This elevation of porphyrin excretion in the 
stool persists during remission. The nature of the defect is not clear 
though suggestions have been made of a defect in the enzymes normally 
preventing oxidation of porphyrinogens to porphyrins(35), or a decrease 
in "cellular reducing potential 11 (66). 
(iii) A separate form of coproporphyria(67) without symptoms 
has been described as hereditary or idiopathic depending on its occur-
rence in more than one member of· a family. 
Acqui~ed 
(i) Acquired porphyria in South Africa is usually related to 
alcohol ingestion(35)(68)(69). The associated skin lesions are 
similar to those occurring in S.A. genetic porphyria. Hyperpigmen-
tation and scarring result(10)(11). Hepatomegaly is associated with 





Acute attacks do not occur. Characteristically the excretion of 
urinary uroporphyrin is increased while faecal porphy~ins are normal 
or only slightly elevated(41)(10)(11). Although it has not been 
demonstrated, an associated genetic defect is possibl~(lO) because 
relatively few patients who chronically consume excessive amounts of 
alcohol, develop porphyria. 
(ii) Another type of acquired porphyria occurred in Turkey in 
persons who had unwittingly ingested insecticide containing hexachloro-
benzene (HCB)(72)(73)(74)(75). 
(iii) A single case has been described of increased porphyrin 
excretion by a patient with a hepatoma(76). The symptoms and signs 
of disordered porphyrin metabolism disappeared following removal of 
the tumour. 
(iv) Various metals and chemicals have been reported to increase 
porphyrin excretion. These include lead(77)(78)(79)(80)(81), aniline, 
arsenicals and methyl chloride, but since the increased porphyrin 
excretion occurs without associated symptoms and is predominantly of 
coproporphyrin, perhaps it is better to include these "chemically-
induced" defects among the many other forms of liver disease in which 
coproporphyrin is excreted in excess(19)(35)(82). 
C: EXPERIMENTAL PORPHYRIA 
(i) In Animals 
A number of compounds have been used to produce abnormal 
porphyrin metabolism in animals similar to human porphyria, but however 
... 
' 
tempting it is to extrapolate such data to the manifestations in man, 
caution must be exercised. The drugs which have been especially used 
in animals are the barbiturates(83)(84) especially Sedormid(83)(85)(86) 
and its analogue AIA, DDC(87), Griseofulvin(88) and HCB(89). A com-
prehensive review up to 1964 is given by Ginsberg(90). Subsequent 
reports on animal experiments have confirmed the role of these parti-
cular drugs in the production of experimental porphyria, but a technique 
devised by Granick(91) using chick embryo liver cells in tissue culture 
has revealed that a much larger number of drugs will induce porphyrin 
fluorescence in such a system. This may provide a valuable means of 
screening drugs for potential toxicity, and is discussed in greater 
detail later, in conjunction with results reported in this thesis using 
the same technique. 
(ii) In Man 
Apart from the recognised exacerbation of acute intermittent 
and S.A. genetic types of porphyria by drugs, the concept of an 
entirely chemic~lly-induced syndrome has fluctuated in popularity. As 
mentioned earlier, first reporters considered that the disease was 
induced only by drugs, but with Waldenstrom's(9) description of a 
latent form of porphyria precipitated by the use of these agents, 
interest moved away from a purely acquired toxic syndrome. The reports 
of experimental porphyria induced in animals(36)(85)(86) provided new 
support which was endorsed by the hexachlorobenzene "epidemic". This 
10. 
appears to represent .the first and only human counterpart described 
thus far of the experimental porphyria produced in animals(92)(93). 
The relationship between a patient with symptomatic porphyria and 
exacerbation of his disease by alcohol, may be regarded as similar to 
that between a patient with acute intermittent or S.A. genetic por-
phyria, and various drugs as yet, chloroquine remains the only drug 
to which a symptomatic porphyria has responded adversely(94), and the 
mechanism of this response is unexplained. 
THE ROLE OF DRUGS IN PORPHYRIA 
The first report of a syndrome apparently precipitated by the 
newly-introduced hypnotics sulphonal, trional and tetronal and asso-
ciated with haematoporphyrinuria, was made in 1889(82A). Numerous 
cases of exacerbation of the various syndromes of porphyria by drugs 
have been cited since then, the relationship being especially well-
defined between acute intermittent porphyria and S.A.genetic porphyria 
and the barbiturates. In these last instances, fatalities have been 
reported(65). 
Some drugs may be tested with extreme caution on patients with 
porphyria, especially if their use is essential to recovery, but for 
the most part, the possible deleterious effects preclude this(94)(95) 
(96)(97)(98)(99). 
Although most reports have been of the deleterious effects of 
drugs in porphyria, some attempts to treat the disease with drugs 
11. 
have been made. These are particularly difficult to evaluate in view 
of the occurrence of complete spontaneous remissions(lOO). Reports 
have been received from Tschudy's laboratory on the effect of dietary 
(101)(102) and hormonal regulation(103)(104) and from Gajdos concerning 
the beneficial effect of the administration of AMP(105)(106)(107). 
The dietary theory of Tschudy relates to the inhibitory effect 
of glucose on many enzymes (which will be reported in greater detail 
elsewhere in this thesis). It was found that a patient(102) with acute 
intermittent porphyria in remission, excreted increased levels of por-
phyrin precursors in the urine when fed a low carbohydrate diet, or 
when isocaloric amounts of fat and protein were substituted for carbo-
hydrate. The levels of these precursors returned to normal with 
resumption of a balanced diet. 
The investigation of the effect of various hormones was motivated 
by the observation that in females with acute intermittent porphyria, 
an acute attack may occur at the time of menstruation(9). The effect 
of progesterone-derived oral contraceptive agents is thought to be the 
inhibition of gonadotrophin secretion with stabilisation of endogenous 
ovarian steroid production(108). The administration of stilboestrol 
(63)(109)(110) and other oestrogen derivatives may result in increased 
porphyrin production, while a case is reported whose symptoms were 
apparently alleviated by the administration of combined ethinyl oestra-
diol and norethynodrel (as Enovid)(103). Several other workers 
12. 
advocate the use of oral contraceptive agents in the treatment of acute 
intermittent porphyria(104)(111)(112). The reports of progesterone-
induced exacerbations are in the minority(l13). 
In bacteria, the administration of adenine nucleotides causes 
diminished ATP levels(l14)ti15)(116)(117)(118). This information and 
a postulate by Shemin(l18) that in porphyria there was a deficiency of 
phosphorylated derivatives of adenosine prompted Gajdos to investigate 
the effect of adenine mononucleotides in experimental porphyria. He 
has reported several successes in experimental animals(l06)(119) and 
in the treatment of acute attacks in acute intermittent porphyria(l05) 
(106)(107). However, no effect was noted when AMP was used in a 
patient with congenital erythropoeitic porphyria(l20), and the value 
of the therapy is not accepted by all investigators. 
THE COMPOSITION OF THE THESIS 
This thesjs is concerned with two aspects of the role of drugs 
in porphyria: 
(i) The value of the tissue culture technique for detection of por-
phyrinogenic agents in vitro as a screening test for such substances 
which may exacerbate human porphyria, and 
(ii) the testing of an hypothesis that drug-induced porphyria is 




Before details of the experimental design and results are given 
porphyrin biosynthesis and its control will be described in chapters 
II and IV, and modern concepts of protein biosynthesis will be briefly 























































































































































































































































































































































































































THE BIOSYNTHESIS OF PORPHYRINS AND HAEM. 
"Porphyria is a genetically determined condition 
with a disturbance of pyrrole or porphyrin meta-
bolism. It is a typical inborn error of metabolism." 
Waldenstrom - 1957. 
A brief outline of the porphyrin biosynthetic pathway is presented 
as a background to the experiments reported in this thesis. (fig. III). 
Since the focal point of the discussion is the enzymic regulation of 
the synthesis of porphyrins, particular attention will be paid to the 
enzyme systems involved, especially to ALA-synthetase. Investigation 
has revealed that of all the enzymes in the biosynthesis tested thus 
far, only ALA-synthetase has been found to be rate-limiting. 
Numerous detailed reviews of the pathway have been published(121-
129) which may be summarised as follows. 
, 
A RESUME OF PORPHYRIN BIOSYNTHESIS. 
Porphyrins, the precursors of haem, are derived from the enzymic 
condensation of 8 molecules of a non-essential amino-acid glycine, 
with succinate which has been activated by combination with acetyl 
co-enzyme-A (Co-A). Shemin, Rimington and Neuberger with various co-
workers(130-138) have been major contributors to the understanding of 
this step with its resultant formation of o< amino ~ ketoadipic acid, 
and the elucidation of the succinate glycine cycle(118)(139). 
Fig: IV 
A SUM MARY OF THE PRINCIPAL FACTORS INVOLVED IN 
THE FIRST STAGE IN PORPHVRIN BIOSYNTHESIS . 
' 
pyridoxal phosphat~ 

























ALA forms by spontaneous decarboxylation of the aminoketoadipic 
acid. The method of conversion of 2 molecules of ALA to PBG was 
elucidated after the determination of the structure of PBG, a pyrrole 
(53)(140). Through an ill-defined polypyrryl methane, 4 molecules 
of PBG undergo isomerisation to form UROgen III. The interaction of 
the 2 enzymes PBG deaminase (UROgen I synthetase)(141) and UROgen 
isomerase (UROgen III cosynthetase)(26) has not yet been fully eluci-
dated. By consecutive decarboxylation of the acetic acid side chains, 
coproporphyrinogen (COPROgen) is formed, and final oxidation of the 
propionic acid groups to vinyl groups results in protoporphyrinogen 
(PROTOgen) 
haem. 
Isomer IX of protoporphyrin incorporates iron to form 
THE ENZYME SYSTEMS INVOLVED. 
The enzymes involved in the biosynthesis have been arbitrarily 
divided by Granick into 3 groups(142): 
Group I: Enzymes of the citric acid cycle culminating in the con-
densation of glycine with succinyl CoA. (fig. IV) 
Group II: The soluble enzymes converting ALA to COPROgen. 
Group III: The enzymes concerned with the conversion of COPROgen 
to haem. 
GROUP I: 
ALA-synthetase is the catalyst of the reaction between succinyl 
CoA and glycine. The presence of this enzyme in animals was first 
16. 
suggested by Laver(137) and by Shemin and Russe11(118)(143). In vivo 
synthesis in man was proposed by Granick when ALA was recovered from 
the urine of a patient with acute intermittent porphyria(144). 
Direct measurement in animal livers has occurred following dicarbeth-
oxy-dihydro-collidine (DDC) and allyl-isopropyl-acetamide (AIA) 
administration(145)(146)(147)._ Granick has devised a micro-method 
for the estimation of ALA-synthetase in the in the livers of porphyric 
~ 
chick embryos induced by AIA(91). Additional information has come 
from the work of Tschudy(61), and Dowdle(62), showing the presence 
in increased amounts of the enzyme in the livers of patients with 
various syndromes of porphyria. 
The factors necessary for ALA-synthetase activity are:-
(a) glycine 
(b) succinyl CoA 
(c) cofactors 
I 
(d) other factors 
(a) Glycine has been found essential for the formation of &LA. 
Various workers have f~und differing concentrations necessary(137) 
(145)(147)(148)(149)(150)(151), but no ALA synthesis occurs in its 
absence(90). 
Radio-isotopic labelling of glycine has shown that all its 
nitrogen atoms(133), and 8 of the ~(methyl) carbon: a~oms may be 
traced into the protoporphyrin molecule(53)(118)(130)(152). Labelled 
Fig: V 
THE CITRIC ACID CYCLE 
~LOACETATE_~ ( acetyl CoA 
dehydrogenase ~ 
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carbon atoms appear also in the methyl groups of various compounds, 
the ureido group of purines, and the ~carbon atom of serine, and into 
ketoglutaraldehyde(143). The remaining 26 carbon atoms of protopor-
phyrin are derived from acetic acid, especially from the methyl 
carbon(152)(153). 
(b) Intermediates of the citric acid cycle (fig. V) exert 
variable influences depending on concentration. Citrate and d-iso-
citrate in particular give the highest yields of ALA and have been 
found to enhance protoporphyrin production(142). However, in high 
concentrations succinate, °'ketoglutarate(137)(148) fumarate, oxalo-
acetate and malate inhibit ALA production by their action of suppres-
sing oxidative decarboxylation of ~ketoglutarate(145)(148). 
While ~ketoglutarate was initially thought to be the precursor 
of ALA, Shemin postulated that the succinyl-CoA complex, as an inter-
mediate of the~ ketoglutarate-succinate reaction, was the actual 
substrate. This concept was confirmed with the demonstration of the 
formation of succinyl CoA from ~ketoglutarate in the presence of CoA 
and nicotine-adenine dinucleotide (NAD). It has also been shown that 
succinyl CoA may be formed directly from succinate, using differential 
labelling of succinate with inhibition by malonate. Greater ALA 
synthesis occurs if succinyl CoA is used as a substrate that if suc-
cinate, CoA or ATP alone are used(154). 
18. 
In 1953 it was shown that ALA could replace succinate and glycine 
as a precursor of porphyrins(143). The formal condensation of glycine 
with succinic acid yielded ~amino ~ketoadipic acid, which could undergo 
spontaneous decarboxylation to ALA(155). Thus the precursors of ALA 
appeared to be finally established. 
(c) Cofactors 
(i) The first and most important of these is pyridoxal phosphate, 
as shown by several lines of evidence. Blood from vitamin B deficient 
ducklings was found to incorporate glycine and succinate at a decreased 
rate(156). Incorporation was restored by the addition of pyridoxal 
phosphate, but other pyridoxal compounds were found ineffective. A 
direct influence has been noted on the porphyrin metabolism of chick 
haemolysates(138)(142)(14~) and in mammalian systems(53)(156)(157)(158) 
diminished ALA synthesis resulted from decreased pyridoxal phosphate. 
In acute intermittent porphyria, the excretion of ALA and PBG decreased 
with the administration of a diet deficient in pyridoxal phosphate 
(157)(159). 
(ii) Other B group vitamins have not shown this close association 
although in the bacterium Tetrahymena vorax diminished riboflavin 
concentration in the culture medium decreased porphyrin synthesis from 
-
glycine and ALA(160)(161), and deficient pantothenate, nicotinic acid, 
thiamine and thioctic acid decreased porphyrin synthesis from glycine. 
No effect was noted with altered folio acid concentration. The effect 
19. 
of biotin in decreasing porphyrin synthesis(143)(168) is unrelated 
to ALA-synthetase activity(162), but pousibly occurs due to diminished 
activity of pyridoxal phosphate in culture media. 
Uroporphyrinogen is the first intermediate of the corrin ring 
of vitamin Bl2, but no relationship has been shown between this vitamin 
and porphyrin synthesis(163)(164)(165)(166). However, Rhodopseudomonas 
spheroides (Rps.sphs), a bacterium capable of porphyrin synthesis, has 
been found to be rich in vitamin B12(167). 
(iii) The increased excretion of ascorbic acid in the urine of 
experimentally porphyric animals may be due to merely a non-specific 
effect of the vitamin on drug metabolising enzymes(167A). 
(iv) In bacteria, adenosine-triphosphate (ATP) stimulates ALA 
synthesis, as it does in haemolysates of chick erythrocytes, using 
auccinate as a substrate, but ATP inhibits ALA-synthesis when~ keto-
glutarate or isocitrate are substrates(148). With citrate as a substrate, 
\ 
addition of ATP to the medium results in increased ALA synthesis(90). 
However, in tissue culture of chick embryo liver cells, addition of ATP 
has been found to inhibit porphyrin production induced by AIA. Experi-
ments performed in this connection will be described later (chapter VIII). 
(v) Coenzy~e A has been found to stimulate ALA ~ynthesis in 
culture systems of chick erythrocytes(137)(145)(148)(154)(168). 
(vi) NAD has only a small effect on ALA-synthetase(90)(138)(142) 
(149). However oxidative phosphorylation has been proved essential to 
20. 
the enzyme by the inhibition of its action by dinitrophenol and the 
barbiturates. The effect of the latter will also be· discussed 
later (chapter V). 
(vii) The effect of magnesium is variable(58)(131)(138)(149)(154). 
Induction of succinyl CoA synthe tase and accumulation of magnesium in 
mitochondria in experimental porphyria has recently been observed(l69). 
However, magnesium appears to control the binding of "messenger" RNA 
(mRNA) to ribosomes and its absence results in disruption of this 
complex. This has only been shown . so far in in vitro preparations, 
but is assumed to pertain in vivo also. 
(viii) Ethylene-diamine-tetraacetic-acid (EDTA) has a pronounced 
stimulatory effect on ALA-synth~tase, which is thought to be through 
the maintenance of structural integrity of the mitochondria(145). 
However. its use as a chelating agent has been advocated in the treat-
ment of acute intermittent porphyria(170)(171). 
(ix) Iron was initially thought to inhibit ALA-synthetase activity, 
thus providing a control mechanism for haem synthesis, by the formation 
of an iron-porphyrin complex(l52)(172). Another mechanism has been 
suggested i.e. indirect enhancement by stabilisation of the Schiff 
base(66)(146) with a role in enzymatic transaminations which depend 
on pyridoxal phosphate as a cofactor(173). 
(x) Ammonia enh~nces the forma tion of NAD which in frozen/thawed 
preparations at least, is essential for the conv~rsion of ~ketoglutarate 
to succinyl CoA(l38)(160). 
21. 
Other factors common to all enzyme regulation include:-
(i) permeability barriers which are thought to be the cause of 
diminished ALA production by preparations which have been frozen and 
thawed(138)(142)(145)(174). 
(ii) oxygenation - although Rps.sphs needs anaerobic conditions in 
the light to produce porphyrins(l75), in most experiments anaerobiosi s 
is found to decrease protoporphyrin formation(150)(161). 
(iii) buffers - of which the phosphate buffer is found best for experi-
ments in vitro with ALA-synthetase; borate, barbitone or Tris have 
been found to diminish activity(137). 
Chemically the reaction is described as the con~ensation of 
pyridoxal phosphate with glycine to form a Schiff base, resulting in 
a stabilised carbanion with the loss of a proton. Further condensation 
occurs with the acyl carbon atom of succinyl CoA acting as an electron 
acceptor. Decarboxylation occurs simultaneously or shortly afterwards. 
Enzyme activity is maximal at pH 6.9, and sulfhydryl groups have been 
found essentia1(176); 
GROUP II: 
ALA-dehydratase, the enzyme involved in the condensation of ALA 
to PBG requires sulfhydryl groups(177)(178)(179) and can be blocked 
by zinc, and other metals, and by EDTA. 
Two steps are said to be involved in the conversion of PBG to 
UROgen. Deaminase condenses PBG to polypyrryl methane with the 
22. 
elimination of NH3, and an isomerase(26) acts through an unknown mecha-
nism to form the isomer III sequence. Heat destroys this isomerase 
activity but PBGenase (deaminase)(141) function remains undiminished 
though the yield is of type I isomers. 
Enzymatic conversion of UROgen to COPROgen requires sulfhydryl 
\ 
groups and either does not require a metal or binds it very tightly. 
The activity is influenced by the availability of the substrate, UROgen, 
which may be oxidised to uroporphyrin on which the enzyme has no effect. 
However, it does also decarboxylate isomer I. Oxidation of porphyrinogens 
to porphyrins is activated by light, and may be influenced by metals and 
glutathione. 
GROUP III: 
COPROgen decarboxylase converts COPROgen III to PROTOgen, but 
has no effect on COPROgen I, which may explain the specificity of 
isomer III conversion to protoporphyrin in nature. Finally, with the 
incorporation of ferrous iron by ferrochelatase (haem synthetase), 
haem is formed. 
CHAPTER III. 
23. 
THE ORGANIZATION FOR PROTEIN BIOSYNTHESIS 
"Protein synthesis is the cardinal manifestation 
of life, and yet the manner in which it is 
achieved is still the great problem of biochemistry 
and of biology" - Felix Haurowitz in Chemistry 
and Biology of Proteins, 1950. 
Inasmuch as porphyrin production results directly from the 
activity of the enzyme, ALA-synthetase, a brief description is given 
of the current concepts of protein, and therefore, enzyme synthesis. 
The primary polypeptide structure of proteins first pro~osed by 
Emil Fischer(180.) has been confirmed by Sanger(181) with the estab-
lishment of the amino acid sequence of insulin, and by du Vigneaud(182) 
with the synthesis of the hormones of the posterior pituitary. The 
studies of Pauling and Corey(183) led to the concept of a secondary 
structure of protein molecules in the form of a helix. A similar 
structure has been shown for the nucleic acids, leading Watson and 
I 
Crick(l84) to propose the double-stranded DNA molecule, and Kornbe:rg(185) 
to its enzymatic synthesis. The concept of the transcription of the 
message encoded in a deoxyribonucleic acid (DNA) molecule to ribo -
nucleic acid (RNA) and its further translation into an amino acid 
sequence with a resultant protein 
Consequent upon this knowledge has come the postulate 
for control of enzyme induction which may be applied to all systems 









































































































































































































































































































































































































































THE FACTORS KNOWN TO BE INVOLVED IN THE 
REGULATION OF ENZYME ACTIVITY AND SYNTHESIS 
Currently, the factors known to be involved in regulation of 
enzyme activity and synthesis(194) are as shown in fig.VI. These 
will be discussed in succession. 
(i) Controllers of enzyme regulation 
Chemical analysis has resulted in the evolution of long-
established controllers of enzyme regulation - these being substrate 
and enzyme concentration, which determine the rate of the reaction, 
and pH, temperature and the presence of inhibitors which combine to 
mediate activity. 
(ii) Factors influencing the size of the enzyme population 
The use of the term "enzyme population'' focuses attention 
on the dynamic aspects of the maintenance of a number of enzyme mole-
cules by a continuous process of renewal and destruction. It empha-
'· sizes the heterogeneity in the stages of synthesis and breakdown, 
and underlines the possibility that certain enzyme molecules may be 
deficient, malformed or inactive(195). It also implies the concept 
of isozymes(196). 
The synthesis and maintenance of an enzyme population depends 
on - (i) the presence of an intact enzyme forming system comprising 
genetic directives from DNA to messenger RNA, 










































































































































































































(iii) the presence of amino acid complexes with soluble RNA, 
(iv) a balanced amino acid pool and 
(v) the availability of energy from glycolysis and/or respiration. 
(iii) The a ctivit;y: of enzi mes 
The activity of enzymes(197) is closely controlled · by the 
presence of co-enzymes and the pyridine nucleotides NAD and NADP; 
flavin derivatives FAD and FMN ; quinones, cytochromes, thiamine pyrro-
phosphate, lipoic acid, biotin, tetrahydrofolic acid, and, of parti-
cular note to this discussion, pyridoxal phosphate, CoA and the 
nucleotide phosphates. 
PROTEIN PRODUCTION VIA RNA FROM DNA 
The dexcription of protein production via RNA from DNA has 
become the subject of numerous reviews and investigations, not all 
of which have been confirmed. The hypotheses which guide current 
experiments on protein synthesis are the Watson-Crick model of DNA(184) 
the discovery of the enzymatic mechanism for DNA replication(185) and 
the elucidation of the DNA-dependent enzymatic synthesis of RNA(l89)(191). 
Protein biosynthesis commences from two points which combine 
after various reactions, and thereafter interreact(198)(204)(fig.VII). 
a)The first point of origin is the DNA helix, one strand of which is 
thought to form the template for RNA, and the other the template for 
renewed DNA synthesis. The concept of base-pairing as first shown by 
Chargaff(205) with the consistent pairing of the bases adenine with 
26. 
uracil (or thymine in RNA) or guanine with cytosine, suggested the 
mechanism for RNA replication. 
The existence of a fraction with the properties of a template 
RNA is suggested by many observations, at first only in bacteria(198), 
but now also in mammalian systems(206)(210). As yet not all conclusions 
are reliable. However at present, current theory embraces the existence 
of such a molecule, known as "messenger" RNA (mRNA), which is thought 
to traverse the cytoplasm from nucleus to ribosome bearing the encoded 
message for amino acid sequence(210A) · 
(ii) The activity of this mRNA in the ribosome is dependent on 
the arrival from the second point of origin, of activated amino acids. 
These are originally free amino acids, activated by specific enzymes 
to combine with ATP(211) and yield enzyme bound amino acid-adenylates, 
which become attached to a low molecular weight soluble or transfer 
RNA (tRNA) also known as the acceptor or adaptor(212)(213X214). 
Binding occurs by an ester bond involving the 2'3'-hydroxyl group 
of the terminal adenosine moeity with the AAC-ending of all transfer 
RNNs(197)(200)(215). The nucleotide sequence of the adaptor is 
specific for a particular amino acid(215)(216), thus recognition of 
the specific amino acid activating enzyme occurs and of the site 
characteristic of the amino acid on the RNA template. The kinetic 
relationship between the ribosome and the messenger RNA 'is uncertain(200) 






RNA moves through the polysome(217). However, it is known that poly-
sames, when extracted in a medium deficient in magnesium, break up 
into constituent ribosomes. The connecting material is thought to 
be mRNA which requires the stabilising presence of magnesium(218) 
(219)(220). 
The code for amino acid sequence is read in the ribosome and 
the correct amino acid selected and positioned. As the peptide bonds 
form, the transfer RNA and activating enzymes are released to further 
amino acid conscription, and on completion of the translation of the 
message, the assembled protein is shed, and mRNA returns to the cir-
culation for further coding(200). The re-utilisation of mRNA is 
suggested by the minute proportion (about 2%) of this fraction 
relative to others(200). 
THE GENETIC CODE 
The genetic code is believed to be comma-less, and is read from 
start to a fixed stop(215)(217). The degeneracy of the code(215)(221), 
that is, the fact that more than one triplet sequence codes for each 
amino acid, has provoked great interest in the language, and recently 
each of the 64 possible triplets (if combinations of nucleotide bases 
are made), has been assigned a purpose(222)(223)(224)(225). Most 
code for amino acids, but as yet the reason for several codes for 
certain amino acids has not been determined. Two of the triplets (UAA 











regard to determining a sequence, but may provide th~ ''punctuation" and 
prevent further reading of the code(223)(226). Interference with 
triplet sequences results in the formation of nonsense triplets which 
prevent adequate pro~ein synthesis. Such interference is the property 
of many antibiotics(227)(228)(229). 
I NHIBITORS 
Much of the information concerning all fractions of RNA has been 
derived from experiments in the use of inhibitors(230). The mechanisms 
involved are of competitive and non-competitive, uncompetitive and 
mixed inhibition(231). The number of recognised inhibitors of nucleic 
acids is increasing. The majority of studies of the effects of 
inhibitors on DNA or RNA involve either the effect of antibiotics on 
bacteria, or various anti-cancer agents on tumour cells in tissue 
culture. Inhibitors may be classified according to their site of 
action in the sequence of protein synthesis. 
(i) Actinomycin D, although known to have anti-metabolic activity 
is under suspicion at present as regards its precise site of action. 
The original suggestion was that of formation of a complex with DNA, 
preventing transcription to RNA(232-236). The property involves 
absolute specificity for guanine and especially for its amino group(237). 
(ii) The mitomyci n group of antibiotics, prepared from Strep-
tomycetes, is thought to cause depolymerisation by forming covalent 
cross-linkages of the strands of DNA, attaching to guanine or cytosine 
29. 
residues or both(238)(239). Phleomycine, the structure of which is 
unknown, is also thought to inhibit transcription by preferential 
binding to the adenine or thymine bases. 
(iii) Puromycin and acetoxycycloheximide inhibit at the ribo-
somal level where the polypeptide chain is assembled(215)(240)(241) 
(242)(243). The former is thought to act by replacing the entrant 
amino acid at the carboxyl end of the peptide chain(241). The anti-
biotics chloramphenico1(215)(242) and chlor-(228) and oxytetra-
cycline(215) also inhibit the incorporation of. amino acids into protein, 
although the ' former has not been found to have this effect in mammalian 
systems. 
(iv) Competitive inhibition is the basis of action of homo-
citrullyladenosine(245) and of 5-fluorouraci1(215)(246). 
(v) Ethionine, although neither an antibiotic nor anti-tumour 
agent, has especial relevance to this discussion because of its triple 
properties of diminution of hepatic ATP and blood glucose, and of its 
induction in rats, of increased porphyrin synthesis. Its effect on 
protein synthesis is not clear, although it is known to form the 
compound s-adenosyl-ethionine in place of s-adenosyl methionine(247) 
and may thereby interfere with trans-methylation reactions. Also, 
-
s-adenosyl-ethionine is known to obstruct oxidative phosphorylation 
in mitochondrial preparations(248). It appears to block the long-
lived protein secreting cells while DNA synthesis continues in the 
30. 
'horter-lived proliferating cells which do not secrete protein(249)(250). 
This may be associated with differences in the effect of ethionine on 
RNA synthesis in the various cell types, or to differences in cellular 
ability to convert ethionine to s-adenosyl-ethionine. More recently 
it has been found that the inhibition of RNA synthesis, in female rats 
fed ethionine follows in time, the decreased ATP concentration, and 
precedes the inhibition in protein synthesis(247). 
(vi) The nuclear protein histone, is reported to inhibit both 
RNA synthesis and nuclear function(251)(252)~ This action of hormones 
is thought to be that of combination with histone, resulting in de-
repression of the operon and uncontrolled mRNA production. 
STIMULATORS 
The stimulatory effect of many hormones on nucleic acid syn-
thesis(253) forms a separate category. Protein synthesis is diminished 
in hypophysectomized rats(254) and growth hormone(255) is found to 
' 
increase the incorporation of amino acids both in these rats and in 
controls, and can restore the amino acid incorporating activities in 
animals injected with Actinomycin D. 
The mechanism of stimulation by cortisol may be through increased 
DNA(256) or by action as an .effector(257). Thyroxin~ accelerates the 
transfer of amino acids from amino acid-RNA to rat liver microsomal 
and ribosomal preparations(258)(259). The stimulatory effect of 










































































































































































































































been studied(260)(261)(262). The mechanism may be interaction with a 
component of the cell with the ability to control protein synthesis, 
or less likely, may directly actNate protein synthesizing systems(261). 
THE REGULATION OF GENETIC EXPRESSION 
A model for the regulation of genetic expression was proposed 
in the Nobel Prize-winning studies of Jacob and Monod(19~)(fig.VIII). 
This envisages various different types of gene, endowed wit~ specific 
activities in the control mechanism. The model consists of four funda-
mental oharacters(176)(263). 
(i) The structural gene(264) is thought to be the DNA segment 
of the chromosome which gives rise to messenger RNA. 
(ii) Tne operon is a segment of DNA consisting of an operator 
gene, and one or more adjacent regulator genes and permease genes, 
and is responsible for the initiation of messenger RNA synthesis. 
(iii) The regulator gene is the DNA segment responsible for the 
production of repressor to block a specific operator. 
(iv) The effector combines reversibly with repressor, to prevent 
inhibition of the operator gene. Effector may also however, combine 
with aporepressor to form repressor. Recent conclusive evidence of 
the existence of a repressor. has been presented(265), 
In this model, the postulated final production of mRNA is the · 
result of a succession of stimuli. The incentive for induction is 
received by the regulat~r gene which prevents any active .repressor 
32. 
from entering the repressor system. The condition of the inactive 
repreesor is noted by the operator gene, which, by its close proximity 
to the structural gene, initiates the transcription to mRNA. In the 
case of repression, an active repressor is formed and no mRNA results. 
This modern concept of protein, and,therefore,enzyme synthesis, 
forms the basis of many of the experiments reported in this thesis. 
33. 
CHAPTER IV THE CONTROL OF PORPHYRIN BIOSYNTHESIS 
" ••• the disturbance in porphyrin metabolism in this disease 
cannot be located in a given organ or a given cellular system, 
but must be explained by modification of enzyme systems which 
are very widely distributed in the whole organism." 
Gajdos - 1955. 
"The mechanism of control of RNA synthesis and function are 
a basic part of the overall control of the mammalian cell." 
Penman - 1967. 
The problem of the regulation of porphyrin biosynthesis(25)(59) 
(266-270) is of especial interest in the elucidation of the various 
syndromes of porphyria. A hypothesis has been developed by Granick(91) 
for the control of porphyrin biosynthesis, and the discussion in this 
chapter is based on the data reviewed in chapters II and II, and upon 
this hypothesis. 
THE REGULATION OF ALA SYNTHETASE ACTIVITY 
(i) Negative feedback inhibition 
The concept of negative feedback inhibition of the action of 
enzymes of the pathway of porphyrin biosyntheeis has been elaborated 
mainly in experiments with Rps. sphs(127)(172)(271). It has been 
found that haem, either as haem-protein or haem-protoporphyrin-metal 
complexes inhibit ALA formation(l27)(172)(266)(270)(272). The 
inhibition of ALA dehydrase(l62) by protoporphyrin has also been 
reported, and Kikuchi(58) in the same system has described the 
presence but not the nature of an inhibitor of ALA synthetase. 
Fig: IX 
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The postulate that instead of inhibition, the action of haem 
is one of repression of enzyme induction has received attention in 
recent years. Both this theory and that of end-product inhibition 
gained importance when the intracellular location of the enzymes of 
the pathway was determined(273)(fig.IX). Granick(145) correlated 
the occurrence· in mitochondria both of electron transport and oxi-
dative phosphorylating systems, with the citric acid cycle enzymes 
necessary for ALA synthesis. The siting of ALA synthetase in the 
mitochondrion was proved in guinea pigs fed DDC(145) and in rats fed 
AIA(61), HCB(274) and DDC. The position of both haem and ALA-
synthetase in the mitochondrion provided support for the role of 
haem in inhibition or repression of ALA-synthetase. In addition, 
haem alters mitochondria - both they and the cristae enlarge(175). 
It is not known whether this change in the mitochondrion is due to 
increased ALA-synthetase, and it would be of interest if the synthe-
tase was found on the cristae. If so, this would account for the 
difficulty with which ALA-synthetase can be washed from mitochondrial 
preparations into the surrounding medium(175). The proposal of this 
localisation of ALA-synthetase on the cristae would require that 
succinyl CoA be generated by ketoglutarate oxidase on the cristae, 
and close juxtaposition of succinyl CoA synthetase and ALA synthetase 
on the cristae is likely in view of the active deacylases which have 



















































































































































































































































(iii) The control of ALA-synthetase and haem synthesis 
A current theory proposed by Granick(91) and others(275) for 
the control of ALA-synthetase and haem synthesis is shown diagram-
matically in fig. X. The importance of ALA-synthetase in porphyrin 
synthesis depends on the fact that it has been shown to be both rate-
limiting(58)(61)(137)(138)(142)(145)(172)(276) and inducible(145)(146) 
(274)(277), c·haracteristics which have not, as yet, been applied to 
any other enzyme in the biosynthesis of porphyrins. 
The scheme as _described makes several assumptions which are as 
yet merely hypotheses(176). These are:-
(i) that globin synthesis may be "turned-on" independent of haem 
synthesis, but 
(ii) because of globin synthesis, the haem synthesis rate increases. 
However 
(iii) no globin polypeptide is completed in the absence of haem. 
These assumptions attempt to account for the lal correspondence 
between haem and globin in a haemoglobin monomer. 
With these hypotheses in mind, the control of haemoglobin 
synthesis may be described as follows, 
Prior to the initiation of haemoglobin synthesis, the operon 
responsible for globin synthesis is activated but repressed by the 
regulator gene. This also applies to the operon for . ALA-synthetase. 
It assumes that the aporepressor produced by the regulator gene 
36. 
requires haem for effectively repressing the operon for ALA-synthetase. 
The entry of the effector substance renders inactive the repressor of 
the globin operon and globin synthesis begins. Erythropoeitin or 
metabolites from neighbouring cells may act as globin effectors, the 
former having been shown to stimulate haem synthesis in the culture 
of bone marrow cells. Globin utilizes free haem, and deprives the 
repressor of ALA-synthetase of its effect, thus allowing the synthesis 
of ALA-synthetase. The selection of free haem as the aporepressor 
for the ALA-synthetase operon obviates the possibility of over-
production of haem, although even if ALA-synthetase formation ceases, 
haem continues to form from pre-formed ALA. An additional regulatory 
mechanism is provided by the histone-like activity upon DNA of haemo- , 
globin in normoblast nuclei. 
Using the above hypothesis, Granick(91) has suggested the presence 
of 3 operons for haem regulation - one situated in each of liver and 
erythroid cells, and one in other cells. He postulates defects in 
one or all of these to explain the various syndromes of porphyria. 
THE REGULATION OF THE SUBSTRATES OF ALA-SYNTHETASE 
(i) Glycine 
Some amino acids other than glycine . have been shown to decrease 
the synthesis of porphyrin from glycine(l42) while a diminished con-
centration of such amino acids has resulted in increased ~LA-synthesis(174), 
The activity of these amino acids is L-cysteine > L-serine > L-arginine> 
L-proline ) L-alanine. Addition to chick haemolysates decreases the 
production of ALA with glycine as substrate but has no effect upon 
PBG production with ALA as substrate. 
It has also been noted that old cultures of Rps. sphs. produce 
more porphyrin, possibly consequent on the diminished amino-acid 
concentration in the culture medium(160). 
(i-a) Pyridoxal phosphate 
Pyridoxal phosphate, being a ubiquitous co-enzyme, is often 
involved in competitive inhibition. The substances L-penicillamine 
(137)(138)(145), cystei~l42) cyanide and isonicotinic hydrazide 
(145)(162) react with the aldehyde group of pyridoxal phosphate 
and prevent the formation of a Schiff's base • 
• 
(ii) Citric acid cycle components 
The role of citric acid componen~s has been the interest of 
Labbe et al.(278)(279) and others who envisage this to be the point 
I 
of control of haem biosynthesis(280). The inhibitory action of 
pyruvate may be competition with succinate to form aminoacetone, or 
with o<ketoglutarate for coenzymes(142). Normal liver preferentially 
converts succinyl CoA and glycine to amino-acetone(145)(281) and the 
concept developed that the rate of condensation of glycine with 
acetyl CoA could regulate the amount of succinyl CoA available for 
haem synthesis(282). This was not supported however, when it was shown 
that elevated levels of ALA and aminoacetone could occur simultaneously 
(142) and that patients excreting large amounts of ALA and PBG also 
excreted aminoacetone(283). 
,a. 
Succinyl CoA may be formed in a number of ways(284): 
(i) as mentioned, via the citric acid cycle from o<.ketoglutarate; 
(ii) directly from succinate and CoA catalyzed by a nucleoside 
triphosphate; 
(iii) from acetoacetyl CoA by the action of a CoA transferase, and 
(iv) especially in animals, from propionyl CoA in combination with 
CO2 and a carboxylating, biotin-containing enzyme, resulting in 
methylmalonyl CoA which is converted to succinyl CoA in the presence 
of a vitamin Bl2 containing enzyme. 
The first-mentioned route is that most likely to be affected by 
events of intermediary metabolism, and has been closely studied by 
Rimington(284). He showed the involvement of the lipothiamide system 
which also implicates availability of oxygen. This has been confirmed 
by the depressant effects on porphyrin production of elevated oxygen 
tension although in vitro effects do not necessarily mirror the 
intracellular state. 
Further proof of the importance of oxygen tension on the bio-
synthesis has come from the observation of the effects of many drugs -
firstly those applied directly for their suppressive effect on oxi-
dative phosphorylation, namely 2,4,dinitropheno1(145)(149)(150) 
iodoacetamide(l37)(138) and p-chloromercuribenzoate which inhibit 
porphyrin synthesis in vitro; and secondly the sedative group of 
drugs(285-288) whose action is through the mechanism of uncoupling 
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oxidative phosphorylation(98)(289) but which in vivo and in vitro 
increase porphyrin synthesis. The presence of an additional effect 
by the drugs is suggested. Seconal has been found to inhibit NADH2-
oxidase and the incorporation of succinate into haem. Acetoacetate 
acts as an oxidant of NADH2 as catalysed by ~OH-butyrate dehydro-
genase, and reverses the inhibition by Seconal. It may also reverse 
the incorporation of succinate inhibited by malonate. This may be 
the reason for the inhibition by Seconal of porphyrin and haem 
synthesis in homogenates, but for the increase of synthesis . in vivo, 
a different behaviour of the compartmented cell is suggested. 
All the enzymes beyond ALA require reduced sulfhydryl groups 
for their action, and are inhibited by heavy metals. Reducing com-
pounds are necessary to prevent the irreversible oxidation of por-
phyrinogens to porphyrins. Modification of the cellular "reduction 
potential" may control whether porphyrinogen is converted to haem or 
to porphyrin. 
The simultaneous increase of haem and fatty acid biosynthesis 
in experimental porphyria has been explained by the block by malonyl 
CoA of the conversion of succinyl CoA to succinate. · succinyl CoA 
is directed to the haem pathway. This possible controlling role of 
malonate has been confirmed by demonstration of the inhibition of 
the incorporation of labelled haem by malonate(278). 
Fumarate reductase and succinyl CO synthetase have recently 
been postulated to be inducible. An increase in succinyl CoA was 
40. 
noted in animals fed AIA with associated increase in the reduction 
of fumarate to succinate; de novo formation of succinyl-Co-synthetase 
and accumulation of magnesium. All these observations precede a 
chemically detectable increase in tetrapyrrole formation(290). 
ANOTHER PATHWAY OF ALA METABOLISM 
The further breakdown of ALA to purines has been proposed as 
a controlling mechanism of porphyrin synthesis(291). Labbe et al 
(292)(293)(294)(295) have noted decreased uric acid concentration 
in the allantoin of chick embryos in which porphyria has been induced 
with Sedormid, but no interference with purine oxidation or excretion. 
They postulate inhibition of purine synthesis with a resulting accumu-
lation of ALA leading to increased porphyrin production. However, 
it was found later by de Matteis et al(296) that there was no evidence 
of impaired purine metabolism in porphyric rats, nor :was there any 
significant change in the levels of nucleic acid or total adenine 
( 





THE I NDUCTION OF PORPHYRIN SYNTHESIS 
IN TISSUE CULTURE USI NG DRUGS AND CHEMICALS 
"It was generally believed that for every ill 
that flesh is heiT to,nature has designated 
some plant as the appropriate cure". 
L.C. Miall - The Early Naturalists.' 
CO NFIRMATION OF TISSUE CULTURE ME THOD 
. Experiments were conducted on a tissue culture system prepared 
from chick embryo liver cells. 
(a)~ from white Leghorn fowls were obtained from the Silver-
sands Poul try Farm, and kept in the incubator of_ the Department of 
Bacteriology, U.C.T. Medical School until their approximate age was 
16-18 days. They were then transferred to the laboratories where the 
tissue cultures were set up under sterile conditions. Taking care to 
avoid incising the gall bladder, the livers were removed and washed 
in a balanced salt solution (Hanks). They were dried of excess fluid, 
weighed, and then transferred to Petri dishes in which they were 
finely diced to a size of about 0.5 mm. using two scalpels. After 
the addition of the culture medium (Eagle's), the cultures were 
placed in an 
. 0 
incubator at 37 C under constant humidity and in an 
atmosphere of 5% CO2 in air. The ~ncubation period after addition . 
of drugs to the medium was 60 hours, and after addition of RNA was 
16 hours. 
., .. , .. ,,., -.. -... -.. ,..-, 
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(b) Hanks solution was prepared according to Pau1(297) by the 
addition to distilled water of:-
NaCl.-8G/L; KC1.-400mg/L; CaC12.-140mg/L; MgS04 ,7H20.~100mg/L; 
MgC12.6H20.-100mg/L; Na2HP04.2H20.-60mg/L; KH2P04.-60mg/L. 
The solution was either passed through a scintered glass filter, or 
sterilized in the autoclave of the Department of Bacteriology at a 
pressure of lOlb./sq. inch for 10 minutes. Lactalbumin hydrolysate 
(DIFCO) 5% in distilled water, glucose-2Gfo and phenol red-20mg/L were 
added and the pH adjusted to 7.2 with 1ml. 5% sodium bicarbonate. 
(c) Eagle's ti§sue culture medium was also prepared according to 
Paul but the recommended amounts of amino acids and vitamins were 
quadrupled(298). 
All amino acids were in the L-form if available and were obtained 
with the vitamins from British· Drug Houses. The concentrations in 




Choline-l;nicotinic acid-l;pantothenic acid-l;pyridoxine-1; 
riboflavine-O;l;thiamine-l;i-inositol-2;f~lic acid-1. 
Stock solution 2 was prepared by addition of arginine, histidine, 
lysine, leucine, isoleucine, methionine , phenylalanine, threonine and 
0 valine to 100 ml. Hanks and heating to 80 C. 
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Stock s.olu tion 3 consisted of tyrosine and cys tine dissolved in 
approximately 50 ml. 0.1 N HCl, but complete solution is never 
obtained. 
Stock solution 4 consisted of all the vitamins with the excep-
tion of folio acid and glutamine dissolved in 200 ml. Hanks. 
The solution of folio acid (stock 5) in 100 ml. Hanks was 
achieved by the addition of a few drops of · 0.5N NaOH until the pH 
is neutral. 
Stock 6 was prepared by the addition of 200,000U penicillin 
and O. 5G streptomyci.n dissolved in 100 ml. distilled water. 
Stock 7 consists of glutamine dissolved in 100 ml. Hanks and 
kept frozen. 
Preparation of 100 ml. of the final medium consisted of 84 ml. 
Hanks, 1 ml. each of stock solutions 2, 3, 5 and 7, and 0.5 ml. 
stock 4. After filtering through a scintered glass filter, 10 ml. 
calf serum was added. This was prepared at the Department of Bacteri-
ology from blood obtained from the Municipal abbatoirs, by Miss S. von 
Olm, and was kept frozen in 15 ml. aliquots. 
Both tissue culture medium and Hanks solution were kept in the 
refrigerator. 
(ii) Method 
Initially the method and i_ntegri ty of tissue culture was con-
firmed using known inducers. The method was adapted .from that 
Fig .XI · 
1 
A normal explant photographed in ultra-violet light . 
Fig XII 







described by Granick(91), although trypsinization of cells was not 
performed. Approximately 20 explants were placed in a small Petri 
dish using a Pasteur pipette, and after allowing a few minutes for 
adherence, were covered with 1 ml. of medium. The diameter of a 
maximum of 0.5 mm. was chosen since the viability and oxygenation of 
such explants is reported to be 70%. Increased concentrations of 
the constituents of Eagle's medium were used to enhance this. 
(iii) Nece s si t y for control cultures 
Because of the variability of porphyrin production by individual 
livers, a control culture was prepared from a common pool for every 
experiment. The stimulation of fluorescence by the addition of ALA 
was used as confirmation that enzyme systems were still intact, if 
it was found that fluorescence was not induced by a _ particular drug. 
(iv) Estimation of porphyr i n fluor escence 
The porphyrin production could be estimated subjectively by 
scanning the explants under a fluorescence microscope. A low power 
of 25x magnification is adequate, and fluorescence is exhibited best 
0 by using an exciting filter of wavelength 3500-4500 A, and a barrier 
filter transmitting above 5200 A. In this case, using a Zeiss 
Ultraphot fluorescence microscope, the exciting filter was BG 12, and 
the barrier filter Zeiss "50". Although the red fluorescence is a 
distinct occurrence (figs XI,XII) it was not felt that great signi-






degrees of intensity of fluorescence in explants, as used by Granick 
with hepatocyte monolayers. Instead it was preferred to reserve 
this technique for the screening of a number of drugs or to determine 
the time required for visible fluorescence to occur, as in the case 
of experiments to be described later, using RNA. 
(v) Quantitation 
(a) Porphyrin extraction. 
For quantitation, the more accurate technique of extraction 
of porphyrins and quantitation using scanning of thin layer chroma-
tographs was preferred. For this method, more livers were used and 
were divided amongst the culture dishes (usually 4). · Each dish con-
tained between 0.5 and 1.0 g. liver in 10 ml. medium. After incu-
bation, explants and medium were transferred to wide-mouthed tubes 
and were separated by centrifugation (2,000 rpm.) 
Porphyrins were extracted from the explants after repeated 
homogenisations in a Potter Elvehjem-type homogeniser with a glass 
pestle. The homogenising solution consisted of a total of 2.5 ml. 
acetone and 0.015 ml. cone. HCl. After 3 centrifugations, the 
combined supernates were adjusted to pH 3.0-3.5 with saturated sodium 
acetate. The end-point was determined by the appearance of a pale 
blue-grey colour when the solution .was tested on Congo red paper. 
To prevent reduction of porphyr~nogens to porphyrins, 0.05 ml. iodine 





three times into butanol:ethyl acetate 1:1. A half volume of petroleum 
ether was added to the pooled extracts and the porphyrins taken into 
2.5 ml. of 1.5N HCl . 
The medium was adjusted to pH 3.0-3.5 using approximately 2.0 ml. 
glacial acetic acid, iodine was added and the porphyrins taken into 
butanol:ethyi acetate. Final extraction with 1.5N HCl was performed 
until the acid layer was no longer pink in UV-light. The combined 
extracts from explants and medium were taken to dryness on a Rotary 
evaporator and each esterified with approximately 5 ml. methanol:sul-
phuric acid (5~) in ~he dark at room temperature for 24 hours. The 
mixture was then adjusted to pH 3.0-3.5 with saturated sodium acetate, 
and the porphyrin methy l esters extracted into 7 ml. redistilled 
chloroform which was then repeatedly washed with distilled water. 
0 The chloroform was dried in a water-bath not exceeding 60 C under a 
stream of nitrogen, and the dried extract dissolved in 100 ~l. 
redistilled chloroform. 
(b) Thin-layer chromatography. 
Using a Hamilton micro-syringe, 10 µl. of the solution of 
porphyrins in chloroform were spotted on a thin-layer chromatography 
plate coated with a layer of Kieselgel G nach Stahl (Merck) of 
thickness 0.2 mm. Ten microlitres of a marker consisting of a 
mixture of proto-, copro- and u~oporphyrin methyl esters, and 5 µl. 
of a coproporphyrin standard were spotted alongside the test samples, 
. 
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and the plate was developed in a solvent of chloroform:kerosene:n-pro-
panol (60:34:2) at 37°c for 45 minutes. After drying, the plate was 
scanned. The scanning device was constructed by Dr G. Sweeney since 
no commercial instruments were available in Cape Town. The construction 
is as follows: exciting light is provided by a Zeiss ST41 high pressure 
mercury arc and incorporates a reflecting mirror, condensing lens and 
Rg365 filter, and is powered with regulated direct current. This 
light falls on a 2mm. slit immediately below the plate being analysed. 
This plate is held on a perspex carriage moved in the direction of the 
long axis of the plate by a small synchronous motor coupled also to 
a potentiometer providing a variable voltage to the X axis of a Moseley 
model I X-Y recorder. Immediately above the layer of adsorbent on 
the upper surface of the plate is a second slit 1 mm. · across and a 
Wratten no.15 filter. Light pa·ssing th~ough a second (1 mm. slit) and 
this filter is focussed on to the photocathode of an IP 21 photomultiplier 
tube. After suitable amplification (photomultiplier photometer,American 
Instrument Co., Silver Springs MD) the output of the tube is fed on to 
the Y axis of the recorder. 
(c) Calculation 
The areas under the peaks which recorded each band of porphyrin 
were measured by means of an OTT hapd planimeter, and the amount of 
porphyrin calculated by comparis9n of these areas with that obtained 
for the standard. Use was made of conversion ·factors to compensate 
.. 
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for the difference in intensities of fluorescence between the copro-
porphyrin and other methyl esters. These factors are 4.77 for proto-
porphyrin and 2.63 for uroporphyrin, and are valid at least over the 
range 0.01 - 1.0 ?g of porphyrin in a given fraction, while the accurate 
detection of porphyrin varies between 0.005 µg and 10 µg. This method 
was derived by Dr G.D. Sweeney from standard porphyrin extraction 
techniques. 
(d) Materials 
All reagents were of "ANALAR" grade and were re-distilled. 
Thin-l ayer ·plates were prepared on standard .apparatus (Shandon 
Scientific Co. Ltd.), and ~ere dried for 45 minutes in a thermostati-
o cally controlled over at 120 C. They were kept in a dessicator until 
required. 
The marker solution was prepared from the methyl esters of 
porphyrins extracted from faeces of patients currently being analysed 
in the laboratory, which were used in arbitrary amounts. 
Coproporphyrin for preparation of the standard was recrystal-
lised from faeces, and an aliquot of the crystals hydrolysed in a small 
amount of 7.5N HCl kept in the dark at room temperature for at least 
48 hours. The pH of the solution was then corrected to 3.5 with 
saturated sodium acetate, and the porphyrins extracted into ether. 
The ether was repeatedly washed .with distilled water to remove any 















































0·12 0·62 0·92 1-23 1,85 2-46 
JJ9 coproporphyrin adjed 
'The coproporpt)irin was dissolved in 1·5N HCl and added to 
tissue culture · Th(2·poq:,iyrin was extracted immed iately. 
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porphyrin found 1n the experimental cultures minus amounts 









Fig: XIV Recovery of free Uroporphyriin • from 
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µg uroporphyrin added 
* The uroporphyrin was dissolved in 1·5N HCl and added to 
tissue culture . The porphyrin was extracted irrmediately. 
/ 
2·68 
The fin!l yields are expnzssed as the amounts of uro -
porphyrin found in the experimental cultures minus amounts 
found in control cultures. 
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Esterification was achieved with 25-30 ml . methanol:sulphuric acid (5%) 
in the dark at room temperature for 24 hours . The . pH of the solution 
was re-corrected to 3.5 with saturated sodium acetate, and the por-
phyrins extracted into chloroform which was washed and finally dried 
on a Rotary evaporator. The dried extract was dissolved in 5. 10 ml. 
chloroform and the solution carefully layered over a column of acti-
vated alumina which had been washed with chloroform. The porphyrin 
was eluted off by the addition of more.chloroform and the adjustment 
of flow rate to 120 dpm. The first fraction obtained contained copro-
porphyrin which coul.d be repurified by drying and repetition of the 
column purification. The final solution was tested by thin-layer 
chromatography to detect impurities. It was then dried and dissolved 
in a known amount of chloroform. A dilution was made and the concen-
tration of porphyrin determined in a Zeiss spectrophotometer. One 
microgram amounts were dried on the Rotary evaporator and stored in 
0 stoppered tubes at -4 C until required. For use, 100 ?l. redistilled 
chloroform was added to dissolve the porphyrin and 5 µl. was used. 
At a photomultiplier sensitivity of O~l, this amount of porphyrin 
yielded an area of approximately 100. 
(vi) The accuracy and reproducibility of these results has been 
tested. 
(a) Known concentrations of free coproporphyrin and uroporphyrin 











• Recovery of Cop:xphyrin methyl ester from 
thin layer chromatographic plates. 
0 
0 0·02 ·04 0·06 0·08 0·1 
)-19 coproporphyrin added 
•coproporµ,yrin mzthyl ester was dissolved in redistilled chloroform 
and sp:,tted on thin layer plates. After chromatography, the amount 
of coproporphyrin was quantitated as described in the text, and 
the actual recovery is shown graphically. Each point indicates 
a single experiment, and the line drawn represents 100°/o recavery. 
' 
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to the culture medium. The porphyrins were extracted immediately and 
the results quantitated. The amounts of the respeptive porphyrins 
produced after subtraction of the amount formed by the control cultures, 
was expressed as a percentage of the amount added. 
The results are shown graphically in figs. XIII and XIV. It 
may be seen that the recovery of ·coproporphyrin averaged 80% and of 
uroporphyrin 90%. This confirms previous studies done in the laboratory 
when the extracted porphyrin was estimated in a spectrophotometer. 
(b) An additional check was made on the accuracy of the chromo-
matography method alone. Various samples of the coproporphyrin 
standards used routinely, were diluted and different concentrations 
chromatographed against a usual standard of 5 µl. The results of 
20 such estimations showed an average recovery of 94% with the range 
86 to 110% (fig. xv). 
In all experiments, incomplete esterification of porphyrins was 
revealed by failure of the chloroform solution to move off the base-
line when chromatographed, and such results were discarded and the 
estimations were repeated. 
EXPERIMENTS USING ALA AND AIA 
(i) ALA. 
With the accuracy of the method thus established, the effect of 
addition of ALA was tested. ALA was dissolved in Hanks solution of 
0.5N saline, in a final concentration of 1 µmole/ml • . A bright red 
Experiments to show the increase in p:,rphyrin prod~tion by 



















CONTROL ALA 1;.ig/ml 
}-19 ix>ri:hyrin / 
Total 
COOH ,l.JQ [X>rphyrin / 
g W.W. gr. g w.w. 
0 .52 2 5.94 
0 ·14 0·94 ~~ 1 .49 
0 -28 ~ 5·65 
0-28 2 4·77 





0·94 0 ·79 
0·68 
~t 63·25 
0·29 2 17·48 
0·61 4 12 ·40 
0·32 8 3·42 
0 ·31 2 2604 . 
0 ·81 1 · 19 4 13·61 
0 ·07 8 10·90 
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CONTROL AIA 3mg/ml 
µg porphyrin Total COOH JJ9 i:x:,rphyri n 
0-52 2 2-63 
0 · 14 0·94 4 0·90 
0·28 8 2·27 
O· 28 2 0-39 
0·52 4 0·28 
O· 24 8 4·48 
O· 13 2 0·04 
0·25 0·62 4 0 · 17 
O· 24 8 5·04 
2 0·36 
1 · 63 1 ·63 
8 6-08 
Q. 93 2 0-86 
O· 23 1 ·48 4 0 · 78 
O· 32 8 3·32 










fluorescence could be detected within 2-3 hours, and porphyrin pro-
duction reached a maximum at 4-5 hours. Dependent . upon the viability 
of the explants and the integrity of enzyme systems, the response to 
ALA was always marked. Table I shows the result of 5 experiments 
using ALA. The range of increase varies from 14 to 100-fold and is 
highly significant (p < 0.001). 
An intact enzyme system is essential to the manifestation of 
fluorescence after the addition of ALA and it is for this reason 
that ALA is used to prove the integrity of enzyme systems. 
It may also be seen from the Table that ALA stimulates the 
formation of porphyrine of all carboxyl groups. 
(ii) The drug AIA has been used by other investigators to 
induce porphyrin synthesis both in animals and in tissue culture. 
The drug in this case was dissolved in Hanks solution or in 0.5N 
saline to a final concentration of 3 mg/ml. Fluorescence was first 
noticeable 24 hours after addition of the drug to cultures, and 
porphyrin production reached a maximum within 36 to 48 hours. How-
ever, at no time was the fluorescence as bright or the porphyrin 
production as great as that occurring after the addition of ALA. 
The results of 5 experiments using AlA are presented in Table II. 
There is a significant (p < 0.001) increase in porphyrin production 
from three to ten-times control levels. It may be seen however, 
that the induction of intermediate carboxyl groups occurred ·less 





A higher concentration of AIA was used than that reported by 
Granick(91); 3 µg/ml failed to induce·porphyrin fiuorescence in 
explants as it had in trypsinized cells, possibly due to permea-
bility barriers. 
Further discussion of the method of action of AIA will be 
discussed after the presentation of experiments conducted with other 
drugs • 
EXPERIMENTS WITH DRUGS AND CHEMICALS 
(i) Ma terials 
The drugs added to tissue culture were the standard pharma-
ceutical preparations, obtained from Groote Schuur Hospital by courtesy 
of the Chief Pharmacist, Mr . Shapiro. The concentrations used of 
many of these were as described by Granick(91), and those not detailed 
by him were prepared in similar concentration. Those not supplied in 
liquid form were dissolved in Hanks solution as required. Other 
constituents of tablets, such as starch and lactose were tested on 
the cultures for effect prioF to commencement of the study. Occasio-
nally, if good dissolution of the tablet could not be obtained, a 
little Pulv. Tragacanth was added. This had been similarly tested 
prior to use. 
Solutions of the drugs were added directly to the tissue culture 
medium before incubation. 
,,,v, ·-.-·._...,. 
TABLE III. 
Drugs whi ch produce fluorescence when added to tissue cul -
ture . 
Dosage is that f ound to produce optimal fluorescence when 
added to 1 ml culture medium . 
Trade Name . 
SEDATIVES: 
Phenobarbitone So -
dium . 4mg 
Pentobarbitone So-
dium . 2mg 
Noludar . 1 mg 
Doriden . 5mg 
Amytal . 1 mg 
Se conal . 1 mg 
Sulfonal . 50pg 
TRANO.UILLIZERS AND 
STIMULANTS . 
Caffeine . lOOpg 
Aller~ron . 2 . 5m~ 




Glu te thimide 
Amo barbital 
Secobarbital 
Nortriptyl·ene HCl . 
Amphetamine . 750pg Amphetamine 
Mil t own . 8mg Meprobromate 
Chemical Name . 
Phenobarbi tone 
Pentobarbitone 
2,4,dioxo - 3,3-diethyl 
5methylpiueridine 










J- phenyl - isopropyl -
amine 
, 
2- methyl - 2n-propyl -
l,3- propBnedi ol,dicar-
bamate 





SEDAT IVES cont. 
Surmontil. 500µg 




Zactirin . 2.5mg+ 
6 . 5mg 
Butaz olidine . 2mg 
Zyloprim . 2mg 
Indo c id . 500µg 
Benemid . 10mg 
Berazolene . 4mg 
Phenazone . 1 mg 
Sodium salicylate . 
1 mg 




Antiphen . 10111g 














Chemica l Name. 
Phenothia zine type 
N ( ¥-di;-nethyl - amino -
propyl ) - imino - dibenzy-
lium HCl . 
Ethoheptazine (lmethyl -
1 - carbethoxy) + acetyl 
salicylic acid . 
3,5 - dioxo-l,2, - diphenyl -
4n- butyl,pyrazolidine 
4- hydroxy,pyrazolo, 
pyrimidine HCl · 
N- nropyl- p - sulphanyl, 
benzoic acid . 
Pyrazolone 
Phenyl - nyrazolone de -
rivative . 
Sodium salicylic acid 
Para - amino phenol deri -
vative 
1,5- nitro - 2- thiazolyl-
2 - i midazolidinone 
2,2 1 - dihydroxy- 5,5 1 -
dichl or o ,diphenyl,me -
thane 
Trade Name. 
ANTIBIOT ICS AND 
ANT I HELM I NTH ICS Contd. 
Generic Name . 
Grisovin, F . P. 2 . 5mg Griseofulvin 
Sulnhadiazine So -
dium. 5µg 
Albamyc in . 50ug 
HORJViONES: 
Syntometrine. 12 . 5mg 
+ 0. 125 i.u . 
Norinyl. 20)1g + 
1 µg 
Stilboestr ol . lOO~g 
Ergometrine . lOµ g 
ANAESTH2TIC AGENTS: 
Pentothal Sodium . 
5mg 
Fabantol . 25mg 
Tubarine . 500)1g 
Flaxedil . 10.ng 
Novobiocin 






Chemical Name , 
Griseofulvin 
Sulphadiazine 
Carbenoy(oxy) - 4- tetra -
hydro,hydroxy, - 3-me -
t hoxy,dimethyl - 6- 6- di -
pyran- 2- yloxyl - 7~h y-
droxy- 4- hydroxy- 4- me -
thyl,butaryl- 2,3- ben-
zamido - 3-methyl - 8-cou-
marine . · 





phenyl) - 3,4 - hexane 
Ergometrine maleate 
Pronyl - 4- n,n,diethyl, 









Le o stesin . 4)1.g 
Viadril. 1 mg 







2 - 6, a cetanilirle HCl 
T21 - hydroxy- uregnane -
3,20- dione sodium 
hemisucc inate . 
TABLE IV. 
Drugs which do not produce fluorescence when added to tissue 
culture . 
Dos8ge ran~~ is to the ontimum resulting in inviability . 
TrP.de Name . 
SEDAT IVES : 
Chloral hydrate . 
1 Opg - 10mg 
Mogadon . lµg - lOOµg 
Ge.neric Name . Chemical Name . 
l,3-dihydro-? - nitro -
5 - phenyl-2H- l,4- benzo -
diazepine - 2 - one 
Spa r ine . 5µg - 5bOµg Promazine 10, 3 1 -di·ne thyl, a:nino, 
nropyl,phenothiazine 
HCl 
Larga c til . 
5µ g - 500µ g 
Chlorproi:nazine 2 - chloro-10,3 1- d5me -
thyl,amino,propyl, 
phenothiazine HCl 
Librium. 5µg - 500µg Chlordiazenoxide ? - chloro - 2 - methyl, 
amino - 5 - phenyl - 3H-
l,4 - benzodiazepine -
4 - oxide 
Soneryl . 5µg - 500µg Butobarbitone 
Stelazine. 
2µg - 20µg 
Melleril . 
2pg - 2 OO)lg 
Milon tin . 
lOµg - 10mg 
Celontin . 
lOp.g - 10mg 
Trifluoperazine 2 - trifluo, methyl,-
10,31 - me thyl, pinera -






Methyl, mercanto - 3 N-
methyl,nineridyl, -
2 - ethyl-10- phenothia -
zine HCl 
N- methyl - ~-phenyl, 
succinimide 
N- methyl - ~- phenyl, 







Trade Name . 
HORi''IONES: 
Mixogen • 
0 . 72pg - 72).lg + 
0 . 9ng- 0 . 09pg 
Syntocinon. 
0 . 001 - 0 . 1 i. u . 
A iiTJ BI OTIC S: 
Chloromycetin . 
lOµg - 1 mg 
ANT I MALARIAL: 
Chloroquine . 
5pp; - 5mg 
VITAMINS: 
Generic Name . 
Oxytoc in 
Chloramphenic ol 
Redoxon . lOµg - 1 mg As c orbic a c id 
Vitamin E. o< tocopheryl 
F'olic a c id. 
2 . 5pg - 250:µg 
CARDIAC AGENTS: 
Digitalis . 
l . 2µg - 1 . 2mg 
Quinidine . 
2µg - 2mg , 
Lethidrone . 
lµ p: - 1mg 
Nenresol . 
5µg - 500ug 
Nalorphine 
Dihydralazine 
Chemical Name . 
Oestradiol-monoben-
zoPte and - phenyl -
propionate ; and testo -
sterone - pron iona te, 
- nhenylproniona te and 
- isocaproate 
Synthetic oxytocin 




Oxo - 3- 1 - gulofurono-
lactone 
1 - ~- tocopheryl aceta te 
Pteroyl - glutami c acid 
Dig italis folia 
Quinidine sulphate 
N- allyl - nor - morphine 
Dihydralazino - l,4-






Trade Name. Generic Name . 
MISCELLA NEOUS: 
Artane . lµg - lOOug Trihexiphenidyl 
Avefortan . 
lug - lOOug 
Avertln . lOµg - 1mg 
Aldomet . 5pg - 5mg 
Dindevan. 
O. lpg - lOpg 
Morphine Sulphate . 
6µg - 600µg 
Pethidine. 
lOpg - 1 mer 
Phenergan. 
2 . 5µg - 2 .5mg 
R2c stinon. 
10)1g - 10mg 
Tensilon . 









Chemical NB.me . 
3,1-piperidyl-l-phe -




Levo- 3,3,4 - dihydroxy-
phenyl - 2 - ~ethylalanine 
Phenindione - 2- phenyl , 
indione -1, 3- dione 
Me thyl-l - phenyl - 4-
ethyl ester of cerboxy-
lic acid - 4- niperidyl -
HCl 
N- 2-dimethylamino -
2- methyl,ethyl,ph eno -
thiazine HCl 
N- 4- methyl;benzene, 
sulnhonyl,N- butyl urea 
3 -hydroxy,phenyl,di -





(ii) The criteria of sel ection of drugs were governed by:-
(a) the likelihood of their use in acute medical conditions, and 
(b) correspondence with the chemical structures already found by 
Granick to induce porphyrin production in tissue cultures. 
In respect of the first consideration, an adequate tranquillizer 
or analgesic for porphyric patients is still sought. The use of 
pethidine or morphine, which appear to be safe from the aspect of 
aggravation of symptoms, carries the risk of addiction. The action 
of other tranquillizers is difficult to assess in such patients with 
disorders of porphy~in metabolism. 
(iii) The r e sults of screening a large number of drugs are found to 
have porphyrin-inducing activity are pres ented in Table III. The 
arrangement is roughly according to use, and includes the optimal 
concentration. A second list of those drugs tested in various dilu-
tions to the limit of viability,which had no effect is shown in 
Table IV. It may be seen that the porphyrin-inducing capacity appears 
predominantly among tranquillizers, analgesics and antipyretics. 
(iv) The results of quanti t ative porphyrin e s t i mation are shown in 
Tables V -XVII. Each positive result was repeated once, and results 
appeared to correlate well with each other. In many cases, three 
dilutions of each dr ug were tested. 
The tranquillizers meprobromate (Miltown), trimipramine (Sur-
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were found to increase porphyrin production, as did the analgesics 
phenylbutazone (Irgaprim), allopurinol (Zyloprim) ~nd indomethacine 
(Indocid). In view of reports already reviewed of aggravation of the 
symptoms of porphyria by hormones, the combination substance Norinyl 
(norethisterone + mestranol) was tested and found to increase porphyrin 
production. Because some of the earliest reports incriminated sulphonal 
and its derivatives, sulfadiazine was tested and found to increase 
porphyrin production. 
In view of the content of lactose in many of the tablets used, 
the effect of lactos~ in tissue culture was investigated. From fig.XV 
it may be seen that lactose in varying dilutions has no effect on 
cultures. Starch, another component of tablets, had been tested by 
screening and did not cause fluorescence. 
The drug, chloroquine; has been found to have a detrimental 
effect in symptomatic porphyria, possibly excluding it from use. Its 
addition to tissue culture results in fluorescence. However, 
amoebiasis occurs frequently in patients who may also take alcohol 
to excess. For this reason, the recently-introduced drug nitro-
thiazolylimidazolidinone (Ambilhar), was investigated. No increased 
porphyrin formation resulted from addition of this drug to cultures. 
However, as will be discussed later, it cannot be immediately extra-






















































































































































































































































































































































































































































































































































































































































































































































































Amphetamine was also tested. 
It was thought that some significance might .be attached to the 
types of porphyrin induced, especially as coproporphyrinuria is a non-
specific result of many diseases. In general, a review of the quanti-
tative results of the drugs tested, revealed no such pattern. However, 
in the testing of the effect of phenobarbitone, it may be seen from 
Table XVIII, the appearance of uroporphyrin occurs consistently only 
with the highest dosag~. However, the concentrations of drugs used 
are in most cases well above those which would be used in therapy, 
and further testing is required to determine whether the production 
of porphyrins other than coproporphyrin is merely a dose response, as 
suggested by the results obtained when using phenobarbitone. 
DISCUSSION OF RESULTS SO FAR PRESENTED 
(i) The most important feature in the interpretation of the 
results of drug screening is to stress again that no direct extra-
polation to human porphyria can be made. However, it is possible to 
state that so far, no drug known to aggravate the condition of por-
phyria in man, has been shown to have a . negative effect in tissue 
culture. Moreover, with regard to the anaesthetic agents, all so far 
tested, including the non-barbiturate preparation Viadril, have 
induced porphyrin synthesis. But tpere are many drugs which have 
a positive effect on the chick liver explants, yet have been used 
with safety so far in porphyric patients - e.g . morphine, pethidine, 
56. 
norinyl. Individual variations in patients are known to occur, with, 
for example, apparent resistance to the developmen~ of an acute attack 
on six occasions of thiopentone anaesthesia, with precipitation of a 
severe reaction after the seventh induction(41). Such variations 
are even more likely to odour in tissue culture. 
Although it could be suggested that the effect is purely non-
specific, the number of agents tested with negative result both by 
Granick and in this series, tends ~o dispute this conclusion. 
(ii) Recent studies on porphyrin induction by Gra.nick have 
suggested that the action of drugs is that of effectors in the scheme 
of haemoglobin biosynthesi~ as discussed in chapter IV. He has 
excluded the possibilities that the increased ALA-synthetase which 
he found in chick embryo .liver systems in vivo made porphyric with 
drugs, was due to a decreased destruction of the enzyme; or that the 
inducing chemical altered the configuration of the enzyme or blocked 
a hypothetical inhibitor. He found no evidence either, of enzyme 
action when drugs were added to isolated mitochondria, or a feed-back 
inhibition when haem was added to isolated mitochondria. 
(iii) The hypothesis of competition with haem, stresses the 
importance of the structures of the porphyrin-inducing drugs. The 
chemical structure necessary to produce porphyria ·in one or ~ther 
experimental form has long been -a source of interest. In 1939, the 
matter was considered by Rimington(300), who recognised a corres-
- .. ..,-~-,-- .. --- -- ~- "'-"""-~-- . 


























































































































































































































pondence with the structure nec e ssary to produce methaemoglobinaemia. 
He postulated the presence of "an amino group unsu~stituted or poten-
tially free, and preferably in such a system that it is capable of 
undergoing oxidation with the formation of a hydroxylamine derivative, 
or a reversibly oxidising system such asp- or o-iminoquinone". 
Subsequent work from the same laboratory(83), and by Labbe, has sug-
gested the importance of the sub-groups of drugs and chemicals(84)(301). 
The basic structure was described by Goldberg and Rimington(83) (see 
fig. XVI)- a dialkyl substituted acetamide or acetamide derivative. 
Labbe(84) proposed in addition, an allyl group as substituent, or a 
3-carbon group, preferably branched. This structure was thought to 
interfere with the function of vitamin Bl2. Granick has described 
five structures for this allosteric inhibition(91). Three are related 
to barbiturate structure and two to collidine design (fig. XVII) . 
The theory that only one site is involved, is confirmed by findings 
that simultaneous addition of two drugs does not result in any 
increased porphyrin production compared with the addition of a single 
agent. Further work on one of the groups proposed by Granick, has 
been performed by Marks(302)(303). Many analogues of DDC and the 
corresponding pyridine have been tested for their properties in tissue 
culture, and their chemical structures have been analysed. 
A study of the Fisher-Hirschfelder-Taylor models and of the 
UV absorption spectra indicated a non-planar relationship between 
58, 
substituents and the ring, which may be important in determining 
porphyrinogenic activity. However, this is only an extension of 
the concept of competition. The work has also involved the investi -
gation of the necessity for free allyl groups which has been described 
in vivo . This was not confirmed in vitro, but the hypothesis was 
proposed that the free allyl group endows the molecule with suitable 
physico- chemical properties which enable it to achieve a significant 
concentration in the liver c~ll, when administered to whole animals. 
The third possibility remains that the chemicals interfere with 
the normal repressio.n of the structural gene for haem, resulting in 
derepression. Estimates of ALA- synthetase activity revealed a 40- fold 
increase in the mitochondria of guinea- pigs fed DDC and an 8- fold 
increase when the drugs were injected into the air- sacs of chick 
embryos confirming one site of · drug action . The proposal that the 
chemicals compete with haem for the site as co - repressor was confirmed 
when with varying concentrations of haem and AIA, the porphyrin-
induc ing effect of the latter was blocked by haem(91) . It was also 
suggested that the corepressor site was not absolutely specific f or 
haem, since deuteroporphyrin and manganese protoporphyrin also 
inhibited porphyrin induction by AIA. 
Two other postulates which have been tested and discarded, are 
(i) that the drugs themselves might in some way act as porphyrin pre-
cursors, and (ii) that ,drugs might interfere with the excretion of bile 
pigments, resulting in a back- pressure and a build- up of porphyrins(299) . 
59. 
(iv) Granick has also proposed that the action of various drugs 
in vivo relates to the response by the liver to such drugs(91). This 
involves the synthesis of detoxifying enzymes. One mechanism of 
detoxication is by hydroxylation of aliphatic groups or aromatic rings 
by various oxidases, which depend for their activity on haem, flavin, 
iron or NADPH2 . One of the terminal oxidases has been found to be a 
cytochrome(304), and increased cytochrome formation has been shown in 
animals following barbiturate administration(305)(306) . It is sug-
gested that a response in man to similar administration of drugs is 
the formation of mor.e haem to assist excretion of the agents. 
This last proposal would explain the fact that many of the drugs 
tested in this series and found positive, do not conform to the 
structures derived by Granick. It appears therefore, that while the 
structural competition with haem by these drugs is a distinct possi-
bility, it must occur in conjunction with another effect. However, 
it may be that as yet insufficient definition of the structures has 
been achieved and that further analysis will reveal either additional 
structures, or a specific planar arrangement . 
OTHER PORPHYRIN-INDUCING SUBSTANCES 
(i) Alcohol 
With respect to the invoivement of alcohol in the syndrome 
of symptomatic porphyria, this substance was added to tissue culture, 













result in fluorescence. As expected, no fluorescence ensued. Because 
a number of alcoholic beverages have as their base . various fusel oils 
(307), a selection of these compounds was tested in dilution. Again 
no fluorescence resulted, and a limiting aspect of the culture system 
became evident - namely that for the establishment of a condition of 
chronic intoxication analogous to that in man by alcohol, animal 
experiments could be more profitably exploited. 
(ii) Fungus 
A surprise discovery was made in 1965 by Keen(308) in this 
laboratory when a co"ntrol culture was found to be fluorescing. Of 
various species tested, only the pigeon liver was found to fluoresce 
spontaneously. This culture of chick liver explants was contaminated 
with a fungus, identified as Aspergillus fumigatus. At present, this 
is being cultivated in larger quantities for possible identification 
of the active principle. The discovery is of interest in two directions 
- the first being the hepatotoxic effect in experimental animals of 
another member of the genus, Aspergillus flavus, and the second con-
cerns the induction of symptomatic porphyria by alcohol, fungal · 
contamination of which may occur under certain circumstances. 
It is evident from all these studies that further investigation 
is required to determine precisely, the nature of the chemical structure 
which has the ability to stimul~te porphyrin synthesis • 
This will be considered in more detail after the presentation of 


















CHAPTER VI THE HYPOTHESIS 
"The fact is only half the truth - the remainder 
depends upon its correct interpretation". 
C.F.M. Saint - Another Look Around. 1967. 
In chapter V, the production of porphyrins by embryo chick 
liver in tissue culture with the addition of drugs and chemicals has 
been confirmed, and the number of drugs which appear to have this 
effect, has been increased. 
The fact that iinhibitors of protein synthesis prevent this 
effect has led Granick(91) to propose that this porphyrin production 
is the result of induction of the rate-limiting enzyme ALA-synthetase. 
Further support for this comes from his experiments in the intact 
chick embryo where increased ALA-synthetase synthesis occurred after 
exposure to AIA. 
The small amount of ALA-synthetase in tissue culture has so far 
defied direct measurement both in Granick's laborato+y and in our own. 
However it seems reasonable to assume that the increased production 
of porphyrin in chick embryo liver cells after exposure to certain 
drugs is the result of increased ALA-synthetase synthesis. 
The hypothesis· was developed that RNA, especially messenger RNA, 
was involved in the induction of ALA-synthetase, and it was proposed 











is formed in such a way that addition of such nucleic acid to a 
system might result in induction of the enzyme in excess of control 
systems. 
This hypothesis was tested experimentally and the results are 
re corded in chapter VII . 
CHAPTER VII THE TRANSDUCTION OF EXPERIMENTAL 
PORPHYRIA, USING RNA 
"It cannot be seen, cannot be felt, cannot be heard, 
cannot be smelt. It lies beh ind stars and under 
hills, and empty holes it fills" -
(i) Ma terials 
"Dark" - J.R.R.Tolkien in The Hobbit, 1937. 
EXPERIMENTS USING TRANSFER AND 
RIBOSOMAL RIBONUCLEIC AC ID (RNA ) 
~istar rats of both sexes were used throughout the investigation 
of the effect of RIA. Female rats were, however, only used where a 
sex-linked difference in response was suspected. The rats were bred 
in the Animal House of the'University of Cape Town Medical School, 
and transferred to a room near the laboratories when required. Their 
cages were of zinc and iron with steel bases, and the temperature and 
humidity of the room were kept constant. 
Allyl-isopropyl-acetamide (AIA) which was received as a gift 
from Messrs . Roche Products, was given by nasogastric tube as a 
12~ w.v. solution in propylene glycol in the dose of 250mg/Kg body 
weight_. 4 doses were given at 12 hour intervals for 48 hours. This 
dose schedule followed that suggested by Ginsburg(90). 
To promote maximal protein synthesis, the rats .were starved for 
the duration of the experiment, but allowed free access to water. 
Control and experimental animals were matched for weight, and were 
killed either by guillotining, or by incision of the aorta under light 
ether anaesthesia after cardiac puncture and removal of the liver 
had been performed. 
The initial technique used for extraction of RNA yielded 
fractions of transfer and ribosomal RNA. The method was performed 
according to DiGirolamo et a1(206) and Henshaw, Revel and Hiatt(209) . 
(ii) Method 
After preparation, the rats were killed by decapitation and the 
livers removed onto cracked ice . Homogenisation was performed in 
3 volumes of ice - cold medium (0 . 25M sucrose; 0 . 003M CaC12; 0.05M tris -
HCL pH 7.6), and the mixture centrifuged at 15,000g for 15 minutes . 
The upper four - fifths of th~ supernatant solution was centrifuged 
for 90 minutes at 104,000g to separate a microsomal pellet from the 
soluble supernate . The supernate was aspirated and made 1% with 
respect to sodium dodecyl sulphate (SDS) before isolation of the RNA 
with phenol:0.05M tris, pH 7.5 (77:23) . This fraction according to 
various authors(206)(209) contains transfer RNA . (Details of sedi-
mentation constants appear on page 66 ). A microsomal fraction was 
similarly isolated from the pellet after suspending it in 0 . 5 original 
liver volumes of homogenising medium containing 1% SDS . (See page66 
for sedimentation constants). 
The final RNA fractions were dissolved in O.lM Na acetate or 
tris buffer and were added to tissue culture in amounts between 300 
400 µg RNA phosphorus . 
Table: XIX 
Experiments to show the increase in porphyrin production by tissue 
culture after addition of tRNA from control and porphyric rats (method I) 
' 
CONTROL PORPHYRIC 
JJQ RNA COOH .ug ~yrn 
Total• 
.ug RNA COOH 
irosph. gr. per g W.W. l]lOsph. gr. 
2 0·23 2 
216 4 0 ·13 1 · 9 182 4 
8 0·06 8 
2 0 ·71 2 
557 4 0·44 2· 1 677 4 
8 
2 
386 4 0·21 1 ·4 345 4 
B 0 ·32 8 
2 
228 4 0·36 2·0 275 4 
8 0·09 8 
2 0·25 
384 4 0·05 0·8 342 4 
8 
2 0·21 2 
234 4 0·04 1 · 2 143 L. 
8 0·03 e, 
2 0·24 2 
509 4 0·12 1 · 2 703 4 
8 0·26 8 
MEAN INCREASE: Porphyric -Control:: 1 · 0 ! 0·61 
(p<0 ·01) 
• µg porphyrin / g wet wt . / ug RNA phosphorus. 
ug p:>rp/'win 






























Estimation of RNA phosphorus was performed by the orcinol 
reaction as described by Schneider(309). The reagent for this reac -
tion is made up by dissolving 0.25g orcinol (BDH) and 0.125g ferrous 
chloride in 25ml . cone. HCl. RNA (0.1 ml) was added to 1.4 ml. Na . 
acetate (O . l M pH 6.0) and 1.5 ml. orcinol reagent. After boiling 
20 minutes the optical density of the green solution ' is read at · 660mµ, 
and the content of RNA phosphorus estimated from the formula 
(OD+ 0.008) - (DNA x 0.013) • 
0 . 116 
lOOpg RNA phosphorus has been found to contain 26.5µg RNA, by 
correlation of a standard curve for RNA phosphorus with the OD obtained 
for known amounts of RNA . 
In the experiments prese~ted, no attempt was made to add the 
same amount of RNA on each occasion, and the amount of porphyrin 
produced was expressed per gram wet weight of liver, and per µg RNA 
phosphorus added . 
(tii) The results of the addition of transfer and ribosomal fractions 
from control and porphyric rat livers are shown. 
Table . XIX shows the result of addition of the tRNA fractions 
from control and porphyric ~at livers. In 7 experiments, the mean 
increase of porphyrin production over control values was 1.0 ! 0 . 61 
which is significant (p < 0.01). In all experiments a small increase 
~=-- -~°"~ -~, a, - = --...,~ ~- ~ , •s ~ ';(<'~ 
- --- ..,..Ai..,,.-,~ .. -"".,. -~~'-• - , ~ •• 
Table: XX 
E><peri rn<Znts to show the increase in porphyrin production by tissue 
culture after addition of rRNA from control and porphyric rats 6-netrod I) 
CONTROL PORPHYRIC 
µg Rf\ll\ COOH LU g pc:ll'liyrin 
Total• 
J.Jg RNA :OOH 
p-lOSµl. gr. per g w.w. phosph. gr. 
2 0·07 2 
330 4 0·16 1 · 5 242 c\ 
8 0 ·07 8 
2 0·54 2 
654 4 0-32 1 ·3 725 4 
B 
2 
621 8 0·43 0·7 609 4 
B 
2 
289 4 0-33 2-7 369 4 
B 0·46 8 
2 0·69 2 
312 4 0-05 2·4 441 4 
a 
2 
261 4 0-04 0 -8 535 4 
8 0·16 8 
2 0 ·29 2 
597 4 o '.·34 1 .4 304 4 
8 0·22 8 
MEAN INCREASE: porphyric- control:: 3 · 8 t 1 .7 
(p<0-001) 
• ,ug porphyrin / g wet wt./ JJQ RNA phosphorus 
UQi:orP¥in 
per g w.w. 































The schliczren pattczrns of tRNA and 
rRNA in a Spinco model E ultra -
cczntrifugcz at 56,000 r.p.m . 
rRNA 2a &185 
tRNA 23 ,18&45 
66. 
of porphyrin synthesis was noted. In Table XX, the results of the 
addition of rRNA fractions from control and porphyric rat livers are 
shown, and it may be seen that the mean increase in 7 experiments is 
greater, namely 3.8 ! 1.71 which is significant (p < 0.001). The 
difference between the increased porphyrin synthesis resulting from 
the addition of the t- and rRNA fractions is also significant (p < 0.02). 
(iV)The identification of RNA 
The identity of the RNA was established by several methods. 
(a) sedimentation constants. The sedimentation constants of the 2 
fractions were deter~ined in a spinco model E ultracentrifuge with the 
invaluable assistance of Dr. A. Polsen. The schlieren patterns are 
shown in fig. XVIII for both fractions of RNA, and from these, the 
constants were calculated. For the ribosomal fraction, the constants 
were 18S and 28S, and for the transfer fraction, predominantly 4S with 
some contamination by ribosomal RNA revealed by the presence of small 
peaks at 18S and 28S. This contamination has been suspected due to 
the slight apparent inductio~ of porphyrin synthesis ;caused by the 
transfer fraction. (see Table ' XIX). 
(b) absorption spectrum . Further study of the ribosomal fraction showed 
an absorption spectrttm in O.lM acetate buffer pH 5.2 "with a charac-
teristic peak at 258mµ, and an absorbance ratio 258/280 mµ of 1.9. 
(c) sucrose gradient. The sedimentation profile in a linear sucrose 
gradient 5-25% revealed a ratio between 28S and 18S components of 2:1. 
This is compatible with the known characteristics of ribosomal RNA(310). 
Table i XXI 
Experiments to sho·"' thrz lack of effect on porphyri n produc-
tion by tissue culture after th~ addition of tRNA and rRNA 
extracted from normal I iver to which 200 mg A-1- A had • 
been added just prior to RNA extraction . 
COOH )Jg porphy- ng p.-/g w..N/ 
SPECIMEN gr. rin /g w.w. total ,ug RNA-P 
Control 4 0 ·15 0·15 
rRNA 2 0·11 
0·22 0-72 
275µg • 4 0 ·11 
rRNA 4 0·10 
0· 18 0-68 
280,ug• 8 0-08 
tRNA 
4 0-14 0 ·14 0 -88 
159 )Jg• 
tRNA 




expressed as µg RNA phosphorus 
67. 
(v) Interpretation of results. 
This porphyrin induction could be interprete~ in several ways 
other than being the result of stimulus by the RNA:-
(a) The fraction might be contaminated with AIA carried over in 
the RNA extraction. 
(b) The enzyme ALA-synthetase, or other enzymes of the porphyrin 
biosynthetic pathway might be contaminating the RNA fraction. 
(c) Other protein substances of unidentified nature might be 
present and stimulate porphyrin induction. 
(d) Contamination with DNA might have occurred in the course of 
RNA extraction. 
(e) The fraction might contain the porphyrin precursors ALA and 
PBG carried over from rat liver. 
(a) Contamination with AIA was excluded by addition to a normal rat 
liver (8.0g) the amount of AIA fed to a 200g rat (200mg), and extrac -
tion of the two fractions from this liver . Addition of this RNA to 
tissue culture resulted in no increased porphyrin production (Table XXI) . 
(b) Estimation of the protein content of a solution of 50pg RNA was 
performed using the Folin Ciocalteau method(311). There was 55 pg 
protein present. 
The amount of the protein material present was also detected by 
paper chromatography of the amino acids present afte.r hydrolysis 
using the method described by Efron et a1(312) . A sample containing 
Table: XXII 
' Experiments to show the lack of inhibition by trypsin on the increased 
porphyrin production by tissue culture nzsulting from the .addition of ,. 
rRNA. 
SPECIMEN 
COOH ..ug p:>rphyrin / g ..ug porphyrin / g 
g-oups wet wt. wczt wt/ ,ug RNA- P 
2 0·42 
E Control 4 O· 11 2·5 X 
RNA 300..ug• p 8 0-22 
T. 2 O· 57 rRNA 
375,ug* 
4 O· 40 4·6 
a O· 75 
I rRNA 375µg .. 2 0·38 
+ trypsin 550µg 4 O· 22 4·7 
e 1 · 18 
2 0, 24 
total porpt¥rin 
trypsin 550..ug 
4 0· 18 0·76 
8 0·34 
2 0·41 
Control 4 O· 22 1 · 9 
RNA 325µg 
.. 
tRNA 2 0·59 
4 O· 51 4·0 
500..ug • 
II 8 0·92 
rRNA 50 0 JJQ • 2 O· 61 
+ trypsin 550.µg 4 O· 72 4·3 
8 O· 84 
total porphyrin 
trypsin 550µg 4 0·59 0·59 
II 
expressed as JJ9 RNA phosphorus 
68~ 
approximately 100 µg RNA was hydrolysed with 5 ml. HCl 7.5N at 
120°c for 16 hours (1 ml. 7.5N HCl hydrolyses 1 mg protein). The 
solution remaining was dried unde r a stream of nitrogen _and redissolved 
in 1.5N NCl. Amounts of the solution from 1 µl to 100 µ\ wer~ spotted 
on chromatography paper which was developed in a solvent of butanol: 
acetic acid:water (12:3:5) for 14-16 hours. The paper was dried at 
0 a temperature of 60 C for 15 minutes and then immersed in a solution 
of 2% ninhydrin in acetone. 
0 . Further drying at 60 C revealed a trace 
of glycine which was barely perceptible when compared with a standard 
solution. This trace was thought to be of little significance in 
comparison with the amount of RNA present. Granick has shown in tissue 
culture preparations that glycine alone has no porphyrin inducing 
effect(91). 
(c) Additional evidence that· the porphyrin-inducing capacity was not 
due to protein contamination was obtained when RNA pre-incubated with 
trypsin (1 mg at 37°c for 60 minutes at pH 7.0) induced porphyrin 
synthesis as before (Table XXII}. 
(d) In the course of each calculation for the orcinol reaction the 
amount of DNA was estimated by the diphenylamine reaction(309). There 
was always negligibie DNA present. 
(e) The standard method of ALA and PBG aetermination used in .the 
laboratory(50) was applied to 1 ml. of a solution containing approxi-
mately 100 µg RNA. 'After adjusting the pH to 6.2 with glacial acetic 
acid, the solution was added to an anion column of Amberlite CG400 
type I. The column was washed twice with 2 ml . H20 and these 
washings added to a cation column of Amberlite CGlOO type I. The 
PBG was eluted from the first column with 2 ml. lN acetic acid and 
0.2 ml. 0.2N acetic acid. The collected eluate was made up to 10 ml. 
' with H20, and to 2 ml. was added 2 ml. Erlich's reagent (2% dimethyl-
aminobenzaldehyde in 6N HCl). The optical density was read immediately 
at 555mµ and the amount of PBG calculated in mg/1 from the formula 
O.D.x 126. The reading, and thus the PBG content, was zero. The 
cation column was washed with 25 ml. water and with 3 ml. 0.5M Na 
acetate to wash out retained water. The ALA was eluted with 7 ml. 
0.5M Na acetate, and 0.2 ml acetyl acetone was added . to the eluate. 
The solution was made up to 10 ml. with acetate buffer pH 4.6. After 
shaking, the solution was boiled for 10 minutes to convert ALA to the 
pyrrole. When cool, 2 ml. Erlich's reagent (2% dimethylaminobenzaldehyde 
in glacial acetic acid+ 16% perchloric acid) was added, and after 
standing 10 minutes, the optical density was read at ·553mµ. The ALA 
content in mg/1 was calculated from the formula O.D.x 45.9. 
reading was also zero. 
(vi) The effect of RNase upon RNA extracted from rat liver: 
This 
RNA was incubated with RNase (in an amount equal to the µg RNA 
phosphorus in the solution, at 37°c for 60 minutes at pH. 5.0), and 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































This inhibition could have resulted from the effect:-
(i) of RNase upon RNA, or 
(ii) of RNase upon tissue culture. 
The detergent sodium lauryl sulphate was used in lOOx concen-
tration to destroy RNase. After the addition of SLS to the pre-
incubated RNA+ RNase mixture again no porphyrin synthesis occurred. 
(Table XXIIIa). However, when SLS was added to RNase and this mixture 
added to RNA, the porphyrin production. by tissue culture to which the 
mixture was added, was increased. (Table XXIIIb). 
These experiments showed that the RNase had acted specifically 
upon the RNA, so that the induction of porphyrin synthesis by the RNA 
was inhibited. 
(vii) The effect of RNase upon the RNA presumed to be induced 
in tissue culture by AIA~ 
When RNase was added simultaneously with AIA to tissue cultures, 
less porphyrin synthesis occurred. (Table XXIV). To exclude the 
possibility that this •as due to an effect of RNase upon AIA, after 
mixture of RNase with AIA, SLS was added and the mixture added to 
tissue culture. Porphyrin synthesis occurred in the amount usually 
seen with AIA. (Tabl~ XXV). 
From Table XXIV it may be seen that the mean. increase in porphyrin 
synthesis induced by the addition of AIA to tissue culture was 1.80 ! 
1~15 which is significant (p <·0.01). 
71. 
With prior incubation of AIA with RNase, there was no significant 
increase in mean porphyrin production when the control and experimental 
cultures were compared (p < 0.2). 
From Table XXV, it may be seen that the addition of SLS to the 
AIA + RNase mixture protected from the inhibitory effect of RNase and 
porphyrin synthesis was significantly increased by 1.44 ~ 0 . 38 
( p <. 0 . 001) • 
It is possible therefore, that incubation of AIA with RNase 
alone prevented porphyrin production because of interference with the 
action of RNA induced in explants by AIA in the tissue culture medium. 
EXPERINIENTS USING RIBOSOMAL AND RIBOSOMAL+ "MESSENGER"RNA. 
It appeared from these experiments that a ribosomal fraction 
from a porpbyric rat liver could induce porpbyrin synthesis in tissue 
culture of chick ~mbryo liver ceils . The ribosomal fraction was 
thought to be that which was already coded for protein synthesis -
that is, it had already received the message to code for ALA-
synthetase synthesis. 
Since the aim was to prove that it is the messenger RNA which is 
responsible for the effect, a technique was employed for the extrac-
tion of a ribosomal plus "rapidly labelled" or messenger fraction. 
( i) Method. 
This method was described by Parish and Kirby (210), and employs 
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' Experiments to show the increase in porphyrin production by tissue culture 
after the addition of (r+m)RNA extracted from livers of porphyric rats (method Il) 
CONTROL PORPHYRIC 
/ug RNA COOH µg porph./ ng p:>rph. / JJQRNA COOH 
phos. gr. gw.w. gw.w./,ugRNA phos. gr. 
107 4 O· 23 2·2 129 4 
340 4 1 · CE 3 ·1 100 4 
184 
4 0 · 16 3·4 127 
4 
8 0-46 8 
4 0 ·19 4 
160 
B 0 ·13 
2·0 125 
8 





8 0 .33 8 
4 0-40 4 
294 8 0,25 2·2 352 8 
288 4 0·44 1 · 5 225 4 
360 4 0 ·41 1 ·5 281 4 
8 0 ·13. 8 
2 0 ·29 2 
367 4 0 ,46 2·8 270 4 
8 0 ·27 8 
2 0 ·07 2 
225 4 0 ·10 1 ·6 272 4· 
8 0 ·1Q A 
2 0 ·55 2 
315 4 0 ·18 2·9 139 4 
8 0 ·19 8 • 
MEAN INCREASE: PORPHYRIC - CONTROL: 8·5 ! 1·9 









































described, for dissociation of the nucleoproteins and for removal of 
residual protein and polysaccharide. The dissocia~ion is further 
aided by increasing concentrations of sodium chloride and the removal 
of proteins by the addition . of 4-amino-salicylic acid. The liver 
was homogenised in 10 vols. medium (SLS-lg; NaCl-lg; 4-amino-salicylic 
acid 6g; secondary butanol 6 ml.; H20 100 ml.) and extracted in an 
equal volume of phenol:cresol mixture by stirring for 20 minutes at 
room temperature. The mixture was centrifuged at 15,000 rpm for 
30 minutes and the aqueous supernate removed. Sodium chloride 2g per 
100 ml. supernate w&s added and the mixture stirred with a half volume 
phenol:cresol for 10 minutes. After centrifugation at 15,000 rpm for 
10 minutes, the supernate was removed and 2 vols ethanol:cresol 
mixture (9:1) was added. The mixture was left at-4°c overnight, and 
then centrifuged at 10,000 rpm· for 10 minutes. The resultant pellet 
was dissolved in O.lM Na. acetate pH 6.o, and the solution made 3.0~ 
with respect to NaCl. 0 After standing for 16 hours at -15 C, the 
mixture was centrifuged at 6,000 rpm for 10 minutes and washed twice 
with ;.OM Na acetate pH 6.0. The final pellet could be dissolved in 
Na acetate O.lM pH 6.0, or stored under ethanol:water 75:25 + 2g Na Cl. 
The sucrose gradient· analysis of this (r + m) RNA is shown (fig. XIX) 
(ii) Results. 
The results of the addition of these two fractions are shown. 
(a) Table XXVI shows the results of 6 experiments with the addition 








































































































































































































































































































second method of RNA extraction. The mean increase in porphyrin pro-
duction induced by this fraction is 2.6 ! 1.16 whiqh is significant 
(p < o. 01). From Table XXVII however, it may be seen that the por-
phyrin induction stimulated by (r + m) RNA was far greater. The mean 
+ increase in 12 experiments is 8.5 1.89, and this result, and a 
comparison of the increases produced by rRNA and (r + m) RNA are 
significant (p < 0.001). 
(_ 
On two occasions the extraction of ribosomal RNA was delayed 
beyond the customary 42 hours. In contrast to results shown above for 
the ribosomal fraction alone, the results of addition of this "late 
ribosomal" fraction also showed increased porphyrin production. This 
was interpreted as being due to completed incorporation of the message 
in the ribosomal fraction. In the initial "early" ribosomal fraction, 
such incorporation had probably not yet occurred. 
The fact that increase in porphyrin production induced by a 
purer fraction of RNA was greater provided some evidence for the actual 
incorporation of the RNA into the explants in tissue culture. Further 
evidence was obtained after the performance of a .time study. 
(b) time study of the rate of increase in porphyrin production 
following addition 0£ RNA to the cultures. RNA was added and the 
porphyrins extracted at increasing intervals thereafter. Fig.XX shows 
the kinetics of the increase in porphyrin production induced by RNA 















































































































































































attainment of maximal porphyrin production is interpreted as evidence 
that metabolism of the RNA occurred, whereas in th~ case of ALA, the 
immediate precursor of porphyrins was provided and required little 
metabolism. 
(c) Dose response. 
Amounts of RNA increasin g from 0.1 to 100 µg were added to 
tissue culture and the porphyrin production response is shown in 
fig. XXI. The increasing porphyrin production with increasing RNA 
addition is further evidence suggestive of the incorporation of the RNA. 
CONCLUSION 
With the exclusion of any contaminating protein material or 
porphyrin precursors, and with the use of a more refined technique of 
extraction of a fraction containing messenger RNA, it was felt 
reasonable to conclude that ·the increase in porphyrin synthesis could 
be ascribed to the RNA confirming the hypothesis presented in chapter VI. 
Since ALA-synthetase is a mitochondrial enzyme, it was assumed that 
some form of incorporation of the RNA into the explants had taken place. 
The problem of the proof of entry of RNA into cells, and whether this 
occurs in a whole or denatured form, has become of great importance in 
many experiments claiming the effect of "alien" RNA upon cells in 
culture. Such reports as are pres~ntly available, will be discussed 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































CHAPTER VIII THE INHIBITORY EFF~CT OF ATP :GLUCOSE 
ON PORPHYRIN SYNTHESIS STIMULATED BY AIA. 
"Underlying the extreme complexity we may 
find a simplicity which escapes us". 
F.Gowland Hopkins. 1917. 
THE INHIBITORY EFFECT OF ATP IN TISSUE CULTURE 
In view of the success claimed by Gajdos in the treatment ~f 
patients with AMP (see chapter II), the effect of ATP in tissue cultur~ 
was tested. 
(i) Results 
The addition of ATP to cultures in which fluorescence was induced 
with ALA had no effect on the increase of porphyrins (Table XXVIII). 
However, in cultures with added AIA, the induction of fluorescence and 
porphyrin production were reduced almost to control levels by the 
addition of ATP (Table XXIX). The addition of ATP to control cultures 
had no effect (Table XXX). 
From these results, it may be suggested that the action of ATP 
occurs at the level of ALA-synthetase or preceding enzymes. As has 
been mentioned, the role of ATP is complex and especially difficult to 
interpret in tissue culture systems. However, it might be concerned 
in two factors of especial interest in porphyrin synthesis. These are: 
(ii) Interpretation of results 
(a) the activity of ATP in the transport of amino acids to the 
ribosome in protein synthesis, as described in chapter III. This 
.,.,..., ' ... ,... ,,,. "'-~."(,.,,.~~~--~:·••:c,,·~ .... .,-~--':::::.·~"":!!'~"''........,, . ~.~ •,,~ .. - - ·-----· . ·--~·..-.~-~"'-""'' ~ ~- ,._ -- ~ ..... .,.~;-
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effect is of non-specific involvement in the control of all enzyme 
synthesis. 
(b) The roles of oxidative phosphorylation and of NAD in the 
control of ALA-synthetase have been described in chapter II. The 
regulation of NAD has been studied especially in connection with the 
effect of alcohol on the liver (313)(314). An attempt has been made 
in this regard, to treat fatty liver with ATP (315). NAD has been shown 
to have roles in the Embden-Meyerhof pathway, the conversion of glucose 
and fructose to sorbitol, and in the metabolism of glyceraldehyde. 
Thia association of NAD and therefore ATP with gluaose metabolism 
may be of significance in the control of porphyrin synthesis. 
THE INHIBI~ORY EFFECT OF GLUCOSE IN VIVO. 
(i) The effect of glucose described by Tschudy, has been discussed in 
chapter II. Administration of glucose apparently reduced the excretion 
of porphyrin precursors by a patient with acute intermittent porphyria. 
In a recent publication from the same laboratory, evidence has been 
presented of the inhibitory effect of glucose admi nistration on the 
experimental porphyria in rate fed AIA. Using a similar design, an 
experiment was performed to test the effect in male and female rats, 
of the administration of glucose with AIA. 
(ii) Materials (a) The animals were prepared with AIA as described in 
chapter VI. Glucose in aqueous solution was given in the dose of 12.5g/Kg 
with an additional dose 3 hours .before commencement of the experiment. 
(b) Blood for glucose analysis was collected into tubes containing 
both heparin and sodium citrate, using a heparinised plastic syringe' 




This is said to be a protective mechanism due to the social habits of 
the animals. It was previously ascertained that tpe : presence of heparin 
did not alter the glucose analysis. 
(c) Resins for the determinations of ALA-PBG were prepared as 
follows. 
Preparation of resins for ALA and PBG determinations 
for ALA - Amberlite CG 120 type I - was resuspended 3x in approximately 
2 vols. 4N NaOH and stirred on each occasion for 4 hours. It was then 
washed in a Buchner funnel until the reaction was neutral to litmus, 
and was resuspended .three times in 2N HCl (stirred for 4 hours each). 
Washing was again performed in a Buchner funnel until the resin was 
free of chloride as judged by the AgN03 test. The resin was stored 
under an equal volume of H20. 
for PBG - Amberlite CG 400 type I - was resuspended 6x in 4 vols. 
distilled water. It was then converted to the acetate form in a large 
column, by running through lM Na acetate until the eluate was free of 
chloride as judged by the AgN03 test, and washed with H20 until free 
of Na as judged by the flame test. ~he resin was stored in lN HCl. 
(iii) Methods 
After preparation, the animals were anaesthetised lightly with 
ether, and cardiac puncture performed for blood glucose analysis~ The 








Thereafter, the liver was removed onto cracked : ice and divided 
for ALA-synthetase and liver porphyrin estimations, which were taken 
as the indices of experimental porphyria. 
' 
(a) ALA-synthetase estimations were performed by Mrs. T. Marks using a 
modification by Dowdle of the method described by Urata and Granick(281). c 
After rough weighing, the livers were washed in ice-cold buffer 
(KCl 0.14M, phosphate 0.05M), and then homogenised by mincing with 
scissors and in 2 volumes of tris EDTA (0.15M tris in 0.02M EDTA pH 7.2), 
using a Potter-Elvehjem-type homogeniser with a teflon pestle. One ml. 
of homogenate mixed .with 1 ml. medium (0.6 ml. H20; 0.2 ml. glycine 
l.OM, pH 7.4; 0.2 ml. Na. succinate, 0.5M) was incubated in an agitating 
water bath at 37°c for one hour. At the same time approximately 5 ml. 
homogenate was removed into stoppered tubes for later phosphorus 
determination, and a blank was · prepared from 1 ml. homogenate, 1 ml. 
medium an~ 2 ml. 10% trichloracetic-acid. Incubation of the test 
samples was terminated by the addition of 2 ml. 10% T.C.A. After 
standing for 10 minutes to allow complete precipitation of proteins, 
and centrifugation at 3,000 rpm 2 ml. clear supernatant was added 
to 0.3 ml. lN NaOH and 0.5 ml. Na. acetate, pH 5-6. The mixture was 
layered on a column bf Dowex-1-acetate (1x3 cm) to adsorb PBG. The 
column was washed with 6 ml. H20, and the washing which contained amino-
acetone and ALA, was combined with 1 ml. acetate buffer pH 4.6 and 
0.5 ml. acetyl acetone. Boiling of this mixture for 10 minutes 
' 
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converted amino-acetone and ALA to pyrrole forms. When cool, the 
mixture was added to a fresh column of Dowex-1-acetate, and the amino-
acetone pyrrole eluted with n-butanol equilibrated with O.OlM NH40H 
(approx. 10 ml.) The column was washed with 5 ml. lM acetic acid, 
and the ALA-pyrrole eluted with 4 ml. glacial acetic acid:methanol 1:2. 
This solution was m~de up to 5 ml. with glacial acetic acid. An equal 
volume of Erlich's reagent was added and the optical density read after 
15 minutes, at 552m~ in a Zeiss spectrophotometer. The blank was passed 
through a column .and read in the same way. A standard solution con-
taining 2.03 mg ALA .was also prepared and read. ALA-synthetase was 
calculated according to the formula 
2.03 x 167.4 x sample O.D. 
standard O.D. 
I -6 and was expressed as mµmole g x 10 • 
(167.4 • molec.wt. 
of ALA-HCl.) 
It has been stressed(90)(317) that results of enzyme estimation 
expressed on a wet weight basis do not reflect the total enzyme activity 
of the whole organ. A choice of reference base should be directed 
towards reducing the influence of metabolically inert substances on 
the apparent enzyme activity with accurate assessment of the amount of 
tissue homogenised. Variations in liver glycogen, fat and especially 
porphyrin could be anticipated, as noted by Ginsburg(90), all of which 
could alter the ratio of active tissue to storage material. In these 
experiments, total tissue phosphorus was chosen as reference base. 




relatively simple and gives an accurate steady base. Previous labora-
tory determination of total phosphorus in a number. of rat livers had 
shown that on average, 3.1 g. phosphorus was present per gram of liver. 
Consequently, the phosphorus determinations were performed on samples 
of the homogenates used for ALA-synthetase determinations, and final 
enzyme levels expressed as 
- 6/ I I . mpmole x 10 mg total phosphorus 3.1 • mpmole gram liver
(b) Liver porphyrins were extracted using a method devised by Dr.G. 
Sweeney(319). After rough weighing, the liver was homogenised in 50 ml. 
acetone using a Virt;is "45" homogeniser. One ml. cone. HCl. was added 
and the mixture shaken vigorously for? minutes. After filtration 
through a small Buchner funnel, the residue was returned to the flask 
to be shaken again with 25 ml. acetone and 2% cone. Hc1,' and then 
filtered. Half of the combined filtrate was added to an equal volume 
of water, and the pH adjusted to 2.0-2.5 with saturated sodium acetate. 
The porphyrins were extracted into 1.5 acetone:acid volumes of ethyl 
acetate, and then into a half volume of ethyl acetatesbutanol lsl. 
The three extracts were combined and washed once with water containing 
0.005% iodine solution (1% in ethanol). A half volume petroleum ether 
(BP 40-60°C) was add'ed and the porphyrins extracted into 1. 5N HCl until 
UV-light screening was negative. This volume was recorded and the O.D. 
of the solution read on a Z~iss spectrophotometer between 380 and 430mp. 
The porphyrin content was caloulated from the formula:-
TABLE XXXI 
Experiments to show the effect of glucose administration on 
various parameters tested in rats made fX)rphyric with A I A. 
CONTROL AIA A I A +glucose 
Estimation (propylene glycol) (250rng/Kg X 4) (12·5gA<gx4) 
m. f. m. t. m f . 
Liver 0,63 0·75 9·1 7· 1 3.5 2.7 
porphyrins 
µg/g t0•4 !0·6 !. 2·9 :!: 1 ·5 t0·7 ~ 1 ·5 
ALA 
synthetase 
53·1 53.5 158·7 227·8 86•7 92·3 
m.uM/gx106 ±17·2 1: 10·5 ±82,6 ±69·6 :t 17·0 ±2£'..,3 
Blood 
gt ucose 80·0 75·0 66·0 
56·0 84·0 157•0 
mg°lo ±12·0 ±12·0 ± 9·0 ±20·0 ±5-0 ±75·0 
All results are expres.sed as a mean of 6 experiments :!: standard 
deviation. 
TABLE XXXIa 
Mean incrczaS(Zs and significances to accompany Table XXXI 
. 
Mean AlA-synthetase Blood glucose Liver ~rphyrins 
AIA-CON1ROL 
90·8 :t 8·9 p<0-001 -15·0 ~1-4 p<0·05 8·3 !: 8·4 p<0·1 ,. m 
f 176·3:!: 7-6 P<0·001 -20·5t4-7 p<0·001 6 ·3 t 1 · 7 p<0·001 
Al A+ glucose-
37·5 ! 2·9 p<O{) 5 11·5±11·9 p<0·1 2 ·7 ~ 0·8 p<0·001 CONTROL m . f 38· 8 t: 2-4 p<O·O 2 245·0±74·9 p<0·001 2·1 ± 1 ·9 p<O·OS 
AIA-
A IA+-g lucose m 55·4 ! 6-2 P <O·O 1 18·0 !7·5 p<0·01 5·6 ~ 2 ·7 p<0·01 
f 35·6 .! 6-6 p <0·01 101 · 0.!64-0 p <0·01 4·3 r 0·3 p <0·01 
Significances of ratios b<Ztvveen results from male& female rats. 
m/f ratio ALA-~nthetase Blood glucose Liver p::,rphyrins 
AfA p <0·05 P< 0·4 p<0·2 
AIA-glucose p <0·7 p < 0 · 1 p <0·3 
' 
81. 
2x0.D. -(0.D. - O.D.) x vol. X 563 X 10-3 
max 430 380 
1.67 x E x wt. liver 
mol. 
563 • moleo. wt. protoporphyrin 
E • 2.75 X 10 5 
mol 
• ?g/g wet 
wt. 
This formula was originally suggested by Sveinsson and Riming-
ton(320) to account for any background interference with optical 
density. 
(v) Results 
It may be seen from the results (Tables XXXI, XXXIa) that animals 
fed AIA became markedly porphyric with elevated levels of ALA-synthetase 
and liver porphyrins, and ~iminished blood glucose levels. The results 
are expressed as a mean of 6 experiments! standard deviation. The 
mean increases in ALA-synthetase and blood glucose in both males and 
females are highly significant~ as also is the increase in liver por-
phyrin production by female rats, (for all, p ~ 0.05). For the increase 
in liver porphyrin production by male rats the significance wasp< 0.05. 
The addition of glucose increased the blood glucose levels in both 
sexes. Despite the fact that blood for glucose analysis was taken 
12 hours after the last administration of glucose, the lev~ls in female 
rats were above the ~ontrol levels. Administration of glucose to male 
rats returned the blood glucose to control levels. 
In comparing the results for liver porphyrin and ALA-synthetase 
estimations in AIA and AIA + glucose-fed rats, a significant decrease 
82. 
in both parameters is noted (p<0.05). A signifioant increase occurred 
in blood glucose levels of glucose-fed rats (p < 0.01). 
The comparison of all r~sults for male and fem~le: rats does not 
show suoh significance. Thus although the administration of AIA results 
in marked experimental porphyria, and glucose appears to protect animals 
from this effect, no significant difference is noted in the protective 
effect, of glucose in male and female animals. It should be stressed 
however, that this protective effect was afforded only by feeding massive 
doses of glucose. Extrapolation to human treatment would re~uire the 
administration of 5Kg glucose to a 70Kg man. 
(v) Discussion. 
The inhibition of various enzymes by glucose was first described 
in 1942(321). The influence of the presence of glucose during growth · 
on the enzymic activities of E.coli was noted. Since then, the effect 
has been observed upon an increasing number of enzymes(332). Induoi-
bility is neither a sufficient nor a necessary oondition for the effect -
many inducible enzymes form in the presence of glucose (323). Also the 
effect is not entirely specific for glucose and· has been noted with 
other closely related compounds (324). · 
Hypotheses which have been proposed to explain th~ glucose effect 
includes- · 
(i) interference with the transport mechanism for the inducer 
of the enzyme (325). 
(ii) that the formation of glucose-degrading enzymes pre-empt 
' 
the internal supply of amino-acids and nucleotides (326)(327). 
(iii) diminution of the level of inorganic phosphorus in the cell 
preventing synthesis of inducible enzymes (328). 
; 
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(iv) catabolite repression - viz. aooumulation of oatabolites of 
gluoose whioh repress the formation of other enzymes(323). 
(v) the aotion of gluoose or a derivative of ·gluoose as a oo-
repressor(329). 
It has recently been postulated by Tsohudy(329A) that the inhibition 
by glucose may in fact be mediated through the mechanism of RNA. This 
po•tulate is based on experiments by Nakada and Magasanik whioh showed -
that synthesis of the mRNA specific for~ galactosidase in E.coli was 
inhibited by glucose. In animal experiments, it has been shown that 
glucose administration inhibits the induction of the hepatic enzymes 
ornithine transa~inase and threonine deaminase(331). 
0
The .theory of 
catabolite repression has al~o been postulated for the effect of glu-
cose upon ALA-synthetase. However, as stressed by Rim~ngton, no bio-
synthetio pathway from glucose to porpbyrin has been described. 
Nevertheless, the faot remains, that one preoursor of porphyrins, viz. 
suocinate, is direotly derived from glucose via the citric aoid oyole. 
The similar origin of ATP appears to be relevant to porpbyrin metabolism 
in view ofa-
(i) the inhibitory effeot of ATP on the induotion by AIA of 
increased porphyrin synthesis in tissue culture. 
(ii) a possible role of AMP in the treatment of human porphyria. 
(ii~) the probable conneotion ~hioh appears in the role of ethio-
nine with diminution ?f gluoose and hepatio ATP levels, and 
the elevation of porphyrin exoretion. The production of 
inoreased porphyrin synthesis by the addition of ethio-
. . 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































THE EFFECT OF GLUCOSE ON RNA. 
To investigate the postulate that the inhibitory effect of glucose 
upon ALA-synthetase production was mediated through the mechanism of 
RNA, an experiment was conducted using rats prepared with AIA and 
with AIA and glucose as described on pa~e76. 
Extraction of RNA was performed using the second method descri-
bed (see page 72) and the ribosomal+ messenger fraction ~as added 
to tissue culture. 
The results are shown in Table XXXII and show significantly 
less porpbyrin synthesis in cultures exposed to RNA extracted from 
the livers of rats fed both AIA and glucose, as compared with por-
phyrin synthesis in cultures exposed to RNA extracted from the livers of 
rats fed AIA alone. The mean decrease by glucose was 5.2 ~ 0.74 
which is significant. (p <. 0.001). 
Discussion 
These experiments suggest that the inhibitory effect of 
glucose upon the increased ALA-synthetase activity induced in rats 
by the administration of AIA, may be mediated through the mecha-
nism of RNA. 
Mechanisms other than that of catabolite repression for this 
inhibition have not yet been described, and it is postulated that 
one such mechanism may be an action upon RNA. However, this action 
is not yet explicable. The involvement of ATP both in protein syn-
thesis and in glucose metabolism brings this substance to mind, 




A DISCUSSION OF THE EXPERIMENTS PRESENTED 
AND IDEAS FOR FUTURE RESEARCH 
"Each man is a new power in Nature. He holds 
the key of the world in his hands. Nature 
offers every morning her wealth to man - she 
is careful to leave all her doors ajar -
towers, hall, storeroom and cellar. In her 
hundred gated Thebes, every chamber is a new 
door." 
R.W.Emerson -The Natural History of Intellect. 
The experiments reported in this thesis have been concerned with 
the induction of increased porphyrin synthesis in tissue culture by 
drugs, and with an investigation of the possible role of RNA in this 
phenomenon. Many problems remain to be solved in both these fields, 
but the solution of one is intimately linked with the further clari-
fication of the other. The following ideas are put forward as a basis 
for future research. 
PORPHYRIN BIOSYNTHESIS 
(1) Further chemical structures which induce porphyrin synthesis 
may emerge after sufficient drugs have been tested. Intensive study 
of these structures may lead to an even clearer understanding of their 
mechanism of action but as stressed before, caution must be exercised 
in the extrapolation of these results to human porphyria. 
(ii) Study of the action of ethionine may yield information 
about . the induction of porphy.rin synthesis by drugs, and the effect 
of such substances ~pon RNA. This analogue of methionine was found 
to produce fatty liver in experimental animals probably through the 
mechanism of diminishing hepatic ATP(332). Such animals became markedly 
hypoglycaemic(333), the effect being more obvious in female rats than 
males. Glucose protected rats fed ethionine from developing fatty 
liver and hypoglycaemia. Noting the diminished levels of hepatic ATP, 
Gajdos investigated ethionine-fed rats for porphyria(334). His results 
showed increased excretion of porphyrins in urine and faeces, and 
increased levels of liver porphyrin. He claimed however, that no 
increase of ALA-synthetase production occurred, although no results 
are presented. Indeed, preliminary results from our laboratory suggest 
that there is increased synthesis of ALA-synthetase. 
Ethionine has also been shown to have various, ~s yet ill-defined 
effects upon nucleotides(247)(250). Combination of the techniques 
described in this thesis for testing the ability of RNA to increase 
porphyrin synthesis, together wlth further knowledge of the mechanisms 
of action of ethionine in porphyrin induction and in RNA synthesis, 
and the effect of glucose upon this, may prove a fruitful field of 
study 
(iii) Recent work has confirmed that the action of many drugs 
upon the liver is that of increasing the smooth endoplasmic reticu-
lum(335)(336)(337)(338). This indicates the stimulus bf the synthesis 
of enzymes concerned with endogenous substances(335). Phenobarbitone 
especially, has been shown to have this effect. These changes are 
associated with increased NADPH-dependent drug detoxication and 
increased microsomal cytoohromes(339). As described in chapter V, 
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Granick(91) has suggested that increased haem synthesis might occur 
in drug detoxication, since one of the drug detoxipating oxidases is 
a cytochrome requiring haem for its activity(305)(305A). It has also 
very recently been suggested by Labbe that all defects in porphyrin 
metabolism are at the level of mitochondrial· electron transport and 
energy generation, with the increase in porphyrin synthesis as a 
secondary occurrence(268). 
Various other drugs capable of ALA-synthetase induction in vitro 
have been shown individually to have other effects which may be asso-
ciated with porphyrin biosynthesis. Analogues of salicylate have been 
found to uncouple oxidative phosphorylation(340); anabolic steroids 
stimulate microsomal enzymes in similar fashion to phenobarbitone and 
polycyclic hydrocarbons(338), with associated accelerated metabolism 
of glucose to glucuronic, L-gulonic and ascorbic acids(341). Sali-
cylates and cinchophen derivatives have been shown to inhibit incor-
poration of amino acids into protein(342). These are probably all 
non-specific effects. 
It is possible that some of the above-mentioned effects, and 
more as yet to be described, may operate in the induction of ALA-
synthetase. 
~~More recent suggestions that enzymes other than ALA-synthetase 
may be rate-limiting in porphyrin biosynthesis, viz. succinyl-Co-
synthetase and fumarate reductase, require additional experimental 
a9. 
evidence similar to that which has been provided for ALA-synthetase. 
The synthesis of one enzyme, or in fact of all men~ioned above, may 
be increased in porphyria. 
Proof of the action of RNA in the synthesis of porphyrin in 
tissue culture would be aided by the direct demonstration of elevated 
levels of ALA-synthetase in these cultures. The amounts of this enzyme 
produced in cultures are very small and difficult to measure by any 
form of column separation since the ALA fraction is lost. Both Tschudy 
(329A) and Granick(91) have described micromethods for measurement, but 
neither of these has . proved entirely satisfactory when applied to tissue 
culture. Direct measurement of this or any enzyme of the porphyrin 
biosynthetic pathway in such small quantities will probably require 
the use of radio-active precursors. Attempts to measure ALA-synthetase 
activity using Cl4-glycine are ·presently in progress in our laboratory. 
While the results of some of the experiments reported in this 
thesis have been interpreted as indicating increased ·synthesis of 
ALA-synthetase, the evidence for this is indirect as previously stated. 
However, if increased porphyrin production is due to another enzyme, 
the conclusions drawn about the roles of drugs and the action of RNA 
are equally valid. Further, the inhibitory effect of glucose, acting 
as it appears to, via RNA, can probably be applied to other enzyme 
systems. 
(v) The suggestion of Kikuchi(58) that a specif-ic inhibitor of 
ALA-synthetase is present in Rps. sphs. requires further investigation 
,.,. '"··· __ ..,_., __ ,-.. -, .. , ... , 
' 
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both for therapeutic reasons and for conclusive proof of the action 
of RNA. 
(vi) The search for a therapeutic agent is of greatest importance 
in the problem of porphyria and the role of drugs. While the mechanism 
of porphyrin induction by drugs via RNA has perhaps been clarified by 
the work described here, the only suggestion of therapy is that of 
glucose. Unfortunately, direct extrapolation from animals to man 
suggests that such therapy would be unwieldy, but with one success 
claimed by Tschudy(102) in this regard, further experimentation with 
patients seem justified. The same justification seems applicable to 
the use o"f AMP which Gajdos(106) has advocated. 
In occasional patients, treatment with progesterone derivatives 
may be of value, and a preliminary survey is in progress in Cape Town. 
The use of glutathione has been reported to delay the induction 
of experimental porphyria in mice by Griseofulvin(178), and further 
work in this direction may be rewarding in view of the number of 
enzymes in porphyrin biosynthesis which depend on SH groups. 
(vii) It is thought that the metabolism of tryptophan may be 
disordered in porphyria(343). Increased tryptophan pyrrolase has 
been found in Sedormid-fed animals(344). Of interest in relation 
to this finding, and the hypothesis discussed in this thesis, are the· 
facts that indole-acetic acid increases mRNA synthesis(}45), and that 
the omission of tryptophan from the diets of mice results in 
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disaggregation of the hepatic polyribosomes(34b). Particular signifi-
cance nas been attached to this in view of the fact that this was the 
only amino acid of which the exclusion had this effect. 
Tryptophan remains the one amino acid in the genetic code which 
has only one coding triplet(221) and it is suggested that its presence 
regulates hepatic protein synthesis at the level of translation of the 
message via RNA(346). This may be of even greater significance ' in a 
situation as envisaged for disordered porphyrin metabolism where the 
control of the production of mRNA for ALA-synthetase is already 
unstable. 
PROTEIN BIOSYNTHESIS 
Further experiments are necessary to support the conclusion that 
the induction of ALA-synthetase synthesis is indeed stimulated by the 
addition of RNA. These are,-
(i) the further purification of the RNA fraction added, and 
(ii) evidence that the RNA has entered the explants. 
(i) Since a metabolite of AIA is a possible contaminant, further 
work is necessary to determine the catabolic pathways of the drug in 
man and animals. 
As mentioned in chapter VII, the RNA is considered to be essen-
tially pure, but that protein may be present in a small amount. In 
recently described experiments(347) using a ribonucleoprotein complex 









ribosomes, globin synthesis was stimulated in a cell-free system to 
which the complex was added. It was shown that both ribonucleo-
protein and RNA were necessary for this synthesis, and it is felt 
that a protein fraction may similarly be necessary for the action of 
RNA as described in the experiments reported in this thesis. 
Purification of the RNA fraction may be achieved by passage 
through a Sephadex column which removes much of the oligonucleotide 
contamination. Addition of such a fraction should result in greater 
porphyrin production if greater entry of mRNA occurs. Comparison of 
the increases of porphyrin production achieved by the addition of RNA 
or ALA to tissue cultures, reveals that the full capacity for porphyrin 
production is not exploited by RNA. This is probably due to limitation 
of incorporation of RNA by permeability barriers at the cell membrane. 
It is also known that the pres~nce of RNase on the cell membrane may 
inhibit entry of RNA, and the addition of protamine sulphate(347) or 
histone(252) has been advocated. 
The dose response of p_orphyrin production to a1di tion of RNA, 
or the kinetics of the induction of ALA-synthetase by RNA are only 
indirect evidence for the entry of RNA into the cell. 
~~Entry of RNA could be shown directly by autoradiography or with 
the use of RNA labelled with Cl4-uridine. If such RNA was added to 
tissue culture, extraction -of an intracellular particle, e.g. ribosomes 
from the tissue culture, and demonstration of the radio-activity 
: .. , .. ,,.<vs·~·-• 'A. • .-.· .•• . ,., ' . ...... , .. :.,;., .--~-----
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entirely in that fragment, would C?nfirm the postulate that RNA had 
entered the explants. Such experiments are planne~. 
Various workers have postulated the entry of alien RNA into cells. 
Initially most work was done with labelled bacterial RNA, entry of 
which was noted by the development of infectivity(349) or the induction 
of bacterial enzyme synthesis(192)(350). However, the demonstration 
of entry of alien non-bacterial RNA has proved more difficult. Sug-
gested evidence has been the increase of protein synthesis(351), the 
induction of enzyme synthesis(352-356), and the demonstration of the 
effect of RNA on asoites tumourcells(357)(358). 
Further experiments are required to show whether the hypothesis 
in this thesis is in fact correct, and whether this may be the first 
demonstration of the induction of enzyme synthesis in mammalian cells 
by alien mammalian RNA. 
SUMMARY. 
This thesis is concerned with an investigation into the 
drug - induc ed porphyrias in animals and in tissue culture . 
As an introduction to the subje ct, the first two chapters 
des cribe the historical background to classification of the 
diseases of porphyrin metabolism, and further details of the 
syndromes which occur . A brief resumJ of porphyrin biosyn-
thesis is given, with especial attention to the first enzyme 
in the biosynthetic pathway, viz . ALA- synthetase . 
Since it has been suggested that the increased porphyrin 
produ c ti on whi ch occurs in tissue culture after the addition 
of various drug s is the result of increased ALA- synthetase 
a c t ,ivity, chapter III is concerned with recent advances in 
the field of protein synthesis and its control . 
In chapter IV, combination of the data on porphyrin 
and protein biosynthesis results in a descriution of the 
control of p orphyrin metabolism . This is also concerned 
princ ipally with the regulation of ALA - synthetase synthe -
sis , but other c ontro l mechanisms are considered . 
The chief experimental ma terial used was a tissue cul -
ture system of chick embryo liver explants . The induction 
of porphyrin synthesis in t~ese cultures was tested. Scree ~ 
ning of 69 agents in frequent use in medical conditions, 
showed that 38 caused f l uorescence of the explants when 
these were viewed under an ultra - violet microscope . 
Quantitative experiments with 12 drugs are described, 
: 
. , 
and the increased amounts of pornhyrin produced are tabula ted . 
These results are discussed with respect to the mechanism 
of drug action . The proposal that this mechanism is one of 
derepression of the operon for ALA - synthetase is considered, 
and from this, the hypothesis is developed thats suitably 
coded RNA fraction fro~ a porphyric animal, when added to 
tissue culture, might induce ALA- synthetase and therefore 
p orphyrin synthesis . 
Various fracti ons of RNA from the livers of rats fed 
Allyl - isopropyl- acetamide (AIA), using 2 different methods 
to extra ct the RNA, were added to tissue culture, and the 
p orphyrins produced were quantitated . A ribosomal fraction 
of RNA induced more porphyrin formation that a trsnsfer 
frs c tion, but further purification of the ribosomal RNA 
showed that a ribosomal plus "messenp:er" component induced 
most porphyrin synthesis, while a ribosomal component without 
11messenger" did so to a lesser degree . These results are pre -
sented in cha pter VII . Evidence for the purity of RNA is 
given and it seemed reasonable to conclude that the RNA was 
of acceptable purity . It is possible, however, that a very 
small amount of protein might be nresent, and that the compo -
nent beinp· dealt with is a ribonucleoprotein complex. 
A time -s tudy of the kinetics of porphyrin production, 
and a do se resp onse curve suggested tha t the RNA was actually 
incorp orated into the metaboli s m of the cells • 
; 
The inhibitory effects of ATP and glucose were investi -
gated - the for~er in tissue culture and the latter in experi-
mentally porphyric animals . Results presented in chapter VIII 
show that the simultaneous addition of ATP to tissue cul-
tures with AIA, results in less porphyrin synthesis than 
addition of AIA alone. The mechar.ism of action of ATP nossi-
bly via protein synthesis is considered. 
Glucose was found partially to inhibit the increas~d 
porphyrin synthesis resulting in rats frorli the administrati on 
of AIA . Tne levels of liver porphyrins, blood glucose and 
ALA- synthetase ip rats fed AIA alone and in rats fed AIA plus 
glucose are compared in the second part of chapter VIII. 
The inhibitory effect of f!luc ose was thoui,ht to occur 
via the mechanism of RNA and th1s p ostulate was investi? ated 
using RNA from the livers · of rats fed AIA alone and from 
rats fed AIA plus glu cose. A diminished porphyrin induction 
by the latter RNA is shown, and the whole evidence for the 
theory of c atabolite repression of enzymes and ALA-synthe-
t ase in particular, is discussed at the end of the chapter . 
The last chapter deals with a consideration of the ex -
perimental data presented and extension of the design to 
further research in the fields of porphyrin and protein bio -
synthesis. 
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